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General introduction 9
1Colorectal cancer (CRC) is the third most common cancer and the second leading cause of death from cancer in the Western world [1,2]. Screening has been shown to reduce 
CRC incidence and mortality [3-6]. The first evidence that colorectal cancer screening 
could effectively reduce mortality dates back 20 years [7]. Despite this fact, population 
screening has long been halted at the level of individual testing and discussions of 
the differences between screening tests. With a wealth of new evidence from various 
community-based studies looking at test uptake, screening-program organization and 
the importance of quality assurance, population screening for CRC has come of age. 
That is, opportunistic individual testing is now shifting towards organized population 
screening with comprehensive monitoring and full-program quality assurance. Health 
councils encourage and support member states to implement CRC screening with an 
organized population-based approach and appropriate quality assurance at all levels. 
In this process, the focus turns from the test alone to the combination of a range of 
factors including the target population, test characteristics, uptake, screenee autonomy, 
capacity, diagnosis and management of the disease, and costs [8]. This thesis aims to 
explore methods to improve and optimize population screening for CRC.
It is generally recognized that endoscopic capacity is insufficient for the increased de-
mand that results from CRC screening programs [9-14]. Growing health care demands 
and costs ask for unprecedented solutions, including selective use of resources, and 
rescheduling of tasks. This includes rescheduling of tasks from physicians to specialized 
nurses. Introducing nurse endoscopists into gastrointestinal endoscopy service may 
provide a solution for the insufficient endoscopic capacity. There are several important 
issues to the establishment of nurse endoscopy. As gastroenterologists are to train 
and supervise nurse endoscopists, it is important that they support nurse endoscopy. 
Therefore, we evaluated the views of gastroenterologists towards nurse performed 
endoscopy in Chapter 2.
The decision to introduce NE should be based upon their competence in performing 
the endoscopy. Data on CRC screening emphasize the need of performing the endos-
copy according to the international recognized quality standards with high patient 
acceptance [15]. Furthermore, costs must be considered. In Chapter 3 we evaluated the 
endoscopic quality and patient experiences of nurse endoscopist performed colonos-
copy. In Chapter 4 we compared the endoscopic quality between nurse and physician 
performed colonoscopy, and evaluated cost differences.
The pathology service also plays an important role in CRC screening since the man-
agement of participants in the program depends on the quality and accuracy of the 
histopathologic diagnosis. Pathology affects the decision to undergo further local or 
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1 major resection, as well as surveillance after screening. In addition, it guides strategies for identifying hereditary CRC syndromes such as Lynch syndrome. Accurate pathologi-
cal assessment is of paramount importance [16]. In Chapter 5 we evaluated the inter-
observer variation in the histological diagnosis of colorectal polyps. In Chapter 6 we 
focused on the accuracy of identifying CRC pathology features known to be associated 
high microsatellite instability (MSI-H). These features are incorporated in various strate-
gies to select cases for germline mutation analysis, in order to identify persons with 
Lynch syndrome. We described the diagnostic test characteristics and inter-observer 
variation of MSI-H associated pathology features for identifying MSI-H CRC.
The last issue addressed in this thesis concerns the field of colon imaging. Colon imaging 
is rapidly evolving and aims to improve CRC screening by lowering patient burden, en-
hancing neoplasia detection or by providing real-time histology. These methods include 
techniques with conventional endoscopes. Others make use of modified endoscopes 
to optimize diagnostic tissue characterization [17]. One such alternative is autofluores-
cence endoscopy. In Chapter 7 we compared autofluorescence endoscopy and white 
light video endoscopy for the differentiation between adenomatous and hyperplastic 
colorectal polyps at the time of a colonoscopy.
In the final chapter 8 the main findings of this thesis are summarized and discussed.
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AbStrACt
Background: Nurse endoscopists (NE) may provide a solution for the insufficient endo-
scopic capacity in colorectal cancer (CRC) screening.
Aim: To determine the views of gastroenterologists about the potential role of NE in 
gastrointestinal endoscopy.
Methods: A postal questionnaire was sent to all registered gastroenterologists (n=301) 
and gastroenterology residents (n=79) in the Netherlands.
Results: 235 of 380 (62%) gastroenterologists and residents completed the question-
naire. Overall, 48% were positive towards introduction of NE, whereas 18% were neutral 
and 34% negative. Respondents expected no major differences in endoscopic quality 
between physicians and NE. Nevertheless, 69% expected that patient experiences would 
be better met by physicians. Multivariate analysis showed that actual experience with NE 
and beliefs that NE are able to provide adequate endoscopic quality and good patient 
experiences, were independent predictors for a positive attitude towards introduction 
of NE (OR 6.6 [2.3–18.4], OR 1.9 [1.2–3.5] and OR 2.1 [1.2–2.9], respectively). Respectively 
89% and 66% of the respondents considered sigmoidoscopy and colonoscopy for CRC 
screening, as appropriate procedures to be performed by NE. Diagnostic and therapeu-
tic endoscopies were considered less appropriate.
Conclusion: The majority of gastroenterologists has a positive attitude towards introduc-
tion of NE, especially for CRC screening endoscopies.
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2
intrOduCtiOn
There is increasing interest and growing demand for nurses to perform gastrointestinal 
endoscopy. This is, among other factors, driven by the increased endoscopic demand 
resulting from colorectal cancer screening programs.
Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the second 
leading cause of cancer-related death in the Western world [1,2]. Screening has been 
shown to reduce CRC incidence and mortality [3,4]. Various countries have therefore 
implemented national CRC screening programs, while many others are about to follow. 
However, to date, more than half of the eligible population of the European Union is not 
being offered any form of screening for CRC [5].
CRC screening can be performed with a variety of methods, in particular; stool tests, 
flexible sigmoidoscopy, colonoscopy and computed tomographic colonography [3]. 
Irrespective of the chosen method for primary screening, any CRC screening program 
considerably increases endoscopic demand either for primary screening or for secondary 
evaluation of patients with a positive primary screening test, and finally for surveillance 
of patients who were identified with a neoplastic lesion. The endoscopic demand in 
many countries outweighs the current supply. This is a major hurdle for the introduction 
as well as continuation of CRC screening in many Western countries [6-11].
Nurse endoscopists (NE) may provide a solution for these capacity problems. NE have 
been shown to be competent endoscopists [12,13]. In the UK, they form an integral part 
of the national gastrointestinal service and, among others, contribute significantly to the 
CRC screening program. The British Society of Gastroenterology (BSG) has approved the 
role of NE for various endoscopic procedures provided they are adequately trained [14]. 
In 2005 over 200 NE were practicing in the UK. Their number had significantly increased 
in only five years [14-16]. The American Society for Gastrointestinal Endoscopy (ASGE) 
supports the use of NE for screening sigmoidoscopy [17]. In 2002 6.1% of all screening 
sigmoidoscopies in the USA were performed by non-physician endoscopists [18]. While 
the role of NE in the UK and USA is expected to further expand, other countries are 
considering the introduction of NE.
The speed and success of such a process will likely depend on the opinions, expectations 
and experiences of physician endoscopists who are to train and supervise NE. However to 
date little is known about the attitude of gastroenterologists towards nurse endoscopy. 
The aim of the present study was to determine the views of gastroenterologists with re-
spect to the role of NE in gastrointestinal endoscopy in a Western European community.
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methOdS
A postal questionnaire was sent to all registered gastroenterologists (n=301) and gas-
troenterology residents (n=79) in the Netherlands in November 2007. The questionnaire 
consisted of four sections. The questionnaire first asked for background information, 
including actual experience of the respondent with NE, or the plan to start with nurse 
endoscopy. The second part of the questionnaire focused on the expectations of the 
respondent regarding the quality of, and patient experiences with endoscopic services 
provided by NE compared to physician endoscopists. With respect to endoscopic qual-
ity, the following items had to be scored; cecal intubation rates, the number of detected 
lesions, and complications. With respect to patient experiences, the items were; pain, 
stress, satisfaction, and patient preferences. Responses had to be given in a closed format 
with scores of 1 to 5, representing substantially or moderately better performance by NE, 
no difference between NE and physician endoscopists, or a moderately or substantially 
better performance by physician endoscopists, respectively. The total scores for endo-
scopic quality and for patient experiences were combined. A mean score less than 3 
meant expectations of better performance by NE, a score of 3 meant an expected similar 
performance, and a score >3 meant expectations of better performance by physicians. 
In addition, the questionnaire asked for the expected effect of NE on costs of endoscopic 
services, to be scored as; a decrease, no effect or an expected increase of costs. The third 
section of the questionnaire determined the attitude of the respondent towards the 
introduction of NE. Respondents could express a positive, neutral or negative attitude. 
The last section of the questionnaire focused on respondents’ opinions regarding ap-
propriate screening, diagnostic and therapeutic endoscopic procedures for NE.
Statistical analysis was performed using the SPSS 15.0 program (SPSS Inc. Chicago, IL). 
Descriptive statistics were used to analyze and report the data. Chi-square tests were 
used where appropriate. Multivariate logistic regression analyses were performed to 
determine which factors predicted a positive response towards nurse endoscopy. A 
two-sided p-value of < 0.05 was considered statistically significant.
reSultS
A total of 235 questionnaires were returned, corresponding with a response rate of 62%. 
Gastroenterologists had a higher response rate than gastroenterology residents (64% vs. 
53%). Of all respondents, 82% was gastroenterologist and 18% was resident. The distribu-
tion of academic versus general hospital employees was 30 vs. 70%. The mean age of the 
respondents was 46 years (SD ± 10 years) and 77% was male. This reflects the distribution 
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of age, sex and work setting of registered gastroenterologists and residents in our country. 
The responses covered all 94 hospitals in the Netherlands. Eleven (12%) hospitals already 
employed a total of 17 NE. Twenty-two percent of all respondents worked in a hospital 
with NE. Eight additional hospitals were considering introduction of nurse endoscopy.
endoscopic quality, patient experiences and costs of ne
Forty-three percent of the respondents expected no difference in endoscopic quality be-
tween physicians and NE, 37% expected physicians to perform better, and 20% expected 
nurses to perform better. With regard to patient experiences, 69% of the respondents 
expected physicians to perform better, 19% expected no difference, and 12% expected 
that patients would be more satisfied with NE than with physician-endoscopists. The 
individual responses for each of the quality and patient experience parameters are 
listed in Table 1. Of note, the majority of respondents expected no difference in the 
number of detected lesions and number of complications between nurse and physician 
endoscopists. However, 43% of the respondents expected that physicians would have 
higher cecal intubation rates. With regard to pain, stress and satisfaction experienced 
by patients, the majority of the respondents expected no difference between nurse and 
physician endoscopists. Nevertheless, 84% of the respondents expected that patients 
would prefer a physician over a nurse endoscopist. Forty-nine percent of respondents 
expected that NE would reduce costs, whereas 41% expected no effect on costs. Re-
spondents’ age, gender, type of hospital (academic or general), or position (resident 
or gastroenterologist) were not related with the expected overall performances of NE, 
except that female gastroenterologists more often than their male colleagues, expected 
better patient experiences for physicians (84% vs. 65%, p = 0.016). The expectations with 
respect to endoscopic quality, patient experiences and costs did not differ between 
respondents from hospitals that already employed NE and respondents with no nurse 
endoscopy experience (p = 0.22, p = 0.34, and p = 0.17, respectively).
Table 1. Individual responses for each of the expected quality and patient experience parameters
nurse better no difference Physician better
Endoscopic quality
- Lesions detection rates 21% 61% 18%
- Complications rates 21% 64% 15%
- Cecal intubation rates 4% 53% 43%
Patient experiences
- Pain 20% 69% 11%
- Stress 15% 67% 18%
- Satisfaction 11% 63% 26%
- Preference 2% 14% 84%
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Attitude towards nurse endoscopy
Figure 1 illustrates the attitude of gastroenterologists towards the introduction of NE. 
Overall, 48.5% had a positive attitude towards such an introduction. Multivariate analy-
sis showed that respondents who actually (had) worked with NE were significantly more 
often positive towards introduction of NE than those who lacked such experience (OR 
6.6 [2.3 – 18.4]). In addition, beliefs that NE are able to provide adequate endoscopic 
quality accompanied by optimal patient experiences were independent predictors for 
a positive attitude towards introduction of NE (OR 1.9 [1.2 – 3.5] and OR 2.1 [1.2 – 2.9], 
respectively). Respondents’ age, gender, type of hospital, position, and expectation 
about costs were not related with the attitude towards nurse endoscopy.
Figure 1. Attitude towards introduction of nurse endoscopists
Potential appropriate procedures for ne
The responses regarding potential appropriate procedures to be performed by NE are 
listed in Table 2. Of note, screening sigmoidoscopy and colonoscopy were considered 
appropriate procedures for NE, by respectively 89% and 66% of the respondents. In 
contrast, only 47% and 45% of the respondents judged diagnostic gastroscopy and 
colonoscopy appropriate for NE, respectively. Furthermore, only 42% considered re-
moval of polypoid lesions smaller than 10mm an appropriate intervention for NE. Other 
therapeutic procedures were considered not to be appropriate at all for NE.
diSCuSSiOn
This study reports the views of gastroenterologists and gastroenterology fellows with 
respect to the potential role of NE in gastrointestinal endoscopy in a Western country. 
Despite the limitations of a postal questionnaire, a representative and reliable overview 
was obtained. The response rate among all Dutch gastroenterologists and residents was, 
with 62%, acceptable.
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Our results show that the majority of gastroenterologists has a positive attitude towards 
introduction of NE for sigmoidoscopy and colonoscopy within a CRC population screen-
ing program (89% and 66% of the respondents, respectively). In contrast, diagnostic 
endoscopies were considered less appropriate and therapeutic procedures were consid-
ered not to be appropriate for NE. Actual experience with NE and beliefs that NE are able 
to provide adequate endoscopic quality or good patient experiences were independent 
predictors for a positive attitude towards introduction of NE.
These results are in agreement with those of a survey in the UK, which predicted an 
important albeit restricted role for NE. Clinicians from the UK considered diagnostic gas-
troscopy and sigmoidoscopy appropriate, and diagnostic colonoscopy and therapeutic 
endoscopies inappropriate for NE. The UK audit however did not specifically investigate 
the attitude towards screening endoscopies [16].
We obtained our results in the setting of a Western European country with a consider-
able shortage in trained endoscopists. This shortage is expected to further increase 
in the next few years, with the pending decision to introduce a nationwide colorectal 
cancer screening program. In the Netherlands, the Individual Health Care Professionals 
Act authorizes nurses to perform endoscopies, provided they do so according to the 
standards of a competent endoscopist as laid down in the regulations of the Dutch 
Society of Gastroenterology. These regulations are endorsed and the adherence to it is 
regularly checked in all Dutch centers by the Dutch Society of Gastroenterologists.
Endoscopic capacity studies performed to date have shown that the currently avail-
able capacity is not sufficient for the increased demand resulting from CRC screening 
Table 2. Potential appropriate procedures for nurse endoscopists.
Procedure Appropriate maybe not Appropriate
Screening
- Sigmoidoscopy 89% 4% 7%
- Colonoscopy 66% 14% 20%
Diagnostic
- Gastroscopy 47% 18% 35%
- Colonoscopy 45% 17% 38%
Therapeutic
- Polyp < 10mm 42% 15% 43%
- Polyp >= 10mm 9% 12% 79%
- Other therapeutic procedures* 4% 5% 91%
* Other therapeutic procedures including: injection of ulcers, banding and injection of varices, dilatation of strictures, stent insertion 
and hot biopsy.
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programs. The magnitude of the capacity problem depends on the chosen modality 
of primary screening, the target population, population adherence with the screening 
program, and finally the surveillance protocol [6-10]. For the Netherlands, recent calcu-
lations have shown that even with the most restrictive screening approach, the number 
of required colonoscopies is likely to double from the current 120.000 to 240.000 per 
annum on a population of 16 million, including 4.4 million inhabitants in the age range 
of 50 – 75 years (data not published). The shortage in endoscopic capacity also varies 
between different regions [10,19]. Together, this asks for more accurate data regarding 
the insufficient endoscopic capacity and the impact of locally chosen solutions.
There are several ways to close the gap between the required and available endoscopy 
resources, respectively focusing on strategies that reduce demand or increase supply. 
Studies have shown that at present 23% to 39% of all gastrointestinal endoscopies are 
being performed for inappropriate indications or at inappropriate surveillance inter-
vals when compared to guidelines [20-22]. Reduction of these unneeded procedures 
would free capacity for other purposes. On the other hand, endoscopic capacity can 
be increased by training of additional endoscopists. However, training of physicians is 
expensive and fellowship programs in gastroenterology are sparse, and slow to respond 
to changes in the need for gastroenterologists [23]. In addition, it has been suggested 
that the need for additional gastroenterologists for endoscopy should be balanced with 
the need for other aspects of gastroenterology care [7]. A more effective way to increase 
endoscopic capacity would be to increase productivity and efficiency of currently avail-
able gastroenterologists [6,23]. This could be accomplished in a strategy where multiple 
adequately trained and productive NE are supervised by an experienced gastroenter-
ologist.
Studies that have investigated the endoscopic skills of NE, concluded that NE are effective 
and can safely perform procedures such as diagnostic gastroscopy and sigmoidoscopy. 
However, most of these studies were criticized for methodological flaws [12,24]. Only 
four randomized controlled trials comparing physicians and NE have been performed to 
date[13,25-27]. In most studies, the methods of training of NE was either not specified, 
or considered inadequate according to current endoscopic training guidelines. Apart 
from gastroscopy and sigmoidoscopy, nurse endoscopy studies have so far not eluci-
dated the possibilities and limitations of NE performing colonoscopy. Such information 
is urgently required in view of the widespread introduction of CRC screening.
With all these developments, guidelines for NE training and criteria to maintain pro-
cedural competence after training should be defined. These guidelines should rely on 
available and future studies regarding the endoscopic skills of NE, and should be well 
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defined for specific procedures. In the UK the Joint Advisory Group on Gastrointestinal 
Endoscopy already developed such guidelines [28]. If competence has been demon-
strated, individual endoscopists should be credentialed by local institutions to perform 
the respective endoscopic procedures. In addition, clear job descriptions must define 
the scope of practice and specific responsibilities for NE and their supervisors. This will 
also clarify the legal implications and effectiveness for the proposed strategy where gas-
troenterologists supervise multiple NE. Furthermore, reimbursement policies should be 
adapted to facilitate a cost-effective and adequate reimbursement. Overcoming these 
issues will allow introduction of NE in the gastrointestinal endoscopic service.
We conclude that the majority of gastroenterologists has a positive attitude towards 
introduction of NE, especially for CRC screening endoscopies. In order to define the ex-
act role of NE, precise assessment of endoscopic quality, patient experiences and cost-
effectiveness is needed. There is especially a need for studies evaluating NE performing 
colonoscopy.
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AbStrACt
Background and study aims: To assess endoscopic quality and patient experiences of 
nurse endoscopists (NE) performing full colonoscopy.
Patients and methods: Ten trained NE were enrolled in this multicenter prospective study. 
One-hundred consecutive colonoscopies of each NE were evaluated for endoscopic 
quality and patient experiences. Colonoscopies were performed under supervision of 
a gastroenterologist, using techniques and protocols of the participating hospitals. 
Patient experiences were measured using a questionnaire.
Results: Nine out of ten NE were female and median age was 43 years (range 35-49). 
Before the start of the study, the NE had performed a median number of 528 colonos-
copies (range 208-2103). In total 1000 colonoscopies were evaluated; mean patient age 
56 years (SD±15), 55% women, 96% class I or II according to the American Society of 
Anesthesiologists physical status classification system. Colonoscopies were performed 
for screening or surveillance in 42%, and for symptomatic indications in 58% of patients. 
The un-assisted cecal intubation rate was 94%, and mean withdrawal time was 10 
minutes (SD±5). Adenoma detection rate was 26.7%. In 229 out of 1000 colonoscopies 
(23%), the NE required assistance from the supervising gastroenterologist. Complica-
tion rate was 0.2%; one perforation and one cardiopulmonary complication. 734/1000 
patients (73%) completed the questionnaire. 694/734 respondents (95%) were satisfied 
with the endoscopic procedure. 530/734 respondents (72%) had no specific preference 
for a physician or nurse endoscopist, whereas 113/734 (15%) preferred a physician 
endoscopist, and 91/734 (13%) preferred a nurse endoscopist.
Conclusions: Nurse endoscopists perform colonoscopies according to the international 
recognized quality standards, with high patient satisfaction.
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intrOduCtiOn
There is increasing interest and growing demand within gastroenterology for nurses to 
perform colonoscopy. This is, among other factors, driven by the increased endoscopic 
demand resulting from colorectal cancer screening programs that are widely being 
introduced.
Colorectal cancer (CRC) is the third most common cancer and the second leading cause 
of death from cancer in the Western world [1,2]. Screening has been shown to reduce 
CRC incidence and mortality [3-5]. CRC screening has therefore been implemented in 
various countries, while being considered by many others [6].
Colonoscopy is the predominant tool for diagnosis and prevention of CRC. Either for 
primary screening, or as next step for any other positive screening test, and finally for 
surveillance of patients who were identified with a neoplastic lesion. Colonoscopies 
account for more than 50% of all current endoscopic efforts in gastroenterology and 
are performed for screening or surveillance in approximately 50% of all colonoscopic 
examinations [7]. Modeling data suggest that the demand for colonoscopy will continue 
to increase [8]. However, in many Western countries endoscopic capacity is insufficient 
to cope with an increased demand [8-13].
Nurse endoscopists (NE) may provide a solution for the inadequate endoscopic capacity. 
NE have been shown to be competent in performing gastroscopy and sigmoidoscopy 
[14,15]. However, to date nurse endoscopy studies have so far not elucidated perfor-
mances of NE performing colonoscopy. Up to now only three studies evaluated nurse 
performed colonoscopy. These small single center reports suggest that NE can become 
competent colonoscopists [16-18]. The aim of the present multicenter study was to 
assess endoscopic quality and patient experiences of NE performing full colonoscopy.
methOdS
All hospitals in the Netherlands with NE undertaking colonoscopies in 2009, were invited 
to participate in this multicenter prospective study. In the Netherlands, rules for health 
care professionals are set by the Individual Health Care Professionals Act (Wet BIG). This 
act authorizes nurses to perform specific delegated tasks, provided they are competent 
in performing the task as determined by training and accreditation, and perform the 
task under a pre-specified level of supervision. All NE had completed their colonoscopic 
training including a minimum of 200 performed colonoscopies, in accordance with the 
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standards for endoscopists in gastroenterology, as laid down in the regulations of the 
Dutch Society of Gastroenterology. All NE were trained to pre-medicate and sedate 
according to the standards set in the Dutch guideline for non-anesthesiologists on 
sedation and/or analgesia at remote locations. Enrolled NE performed 100 consecu-
tive colonoscopies per endoscopist, which were evaluated for endoscopic quality and 
patient experiences. Colonoscopies were performed in patients referred for diagnostic 
colonoscopy including asymptomatic patient referred for screening or surveillance, and 
symptomatic patients. Patients under 18 and referred for therapeutic procedures were 
excluded. All patients had a pre-procedural assessment by a physician familiar with the 
patient and the procedure. The physical status of patients was assessed via the ASA 
classification system. Patients were informed about the endoscopy and administration 
of sedation including its benefits, risks and limitations, as well as possible alternatives. 
After informed consent was obtained, a physicians order was administered to perform 
the endoscopy with or without conscious sedation. Colonoscopies were performed 
using the preparation and techniques according to the protocols of the participating 
hospitals. Immediately prior to the procedure, the NE conducted a brief re-assessment 
of changes in the patient`s history, ASA risk score, medication use, and consent for 
the endoscopy and sedation. NE were allowed to administer and control the sedative/
analgesic medications with a physician’s order. All endoscopies were performed under 
indirect supervision of a gastroenterologist. The supervisor was not present in the room, 
but was present in the endoscopy unit, and on-demand immediately available for tech-
nical or diagnostic advice or in case of complications. The study was approved by the 
ethics committee review board.
nurse, patient and procedure characteristics
At baseline NE age, gender, and endoscopic experience was obtained. Endoscopic 
experience was defined as the total number of colonoscopies performed before the 
start of the study. In addition, the scope of practice with respect to the use of sedative 
premedication, and performing polypectomies was obtained. The following patient and 
procedure characteristics were assessed; patient demographics, ASA-risk score accord-
ing to the American Society of Anesthesiologists physical status classification system, 
referrer, indication, premedication, bowel preparation, whether cecal intubation was 
successful or not, cecal intubation time, withdrawal time, detected lesions, needed 
supervision, and complications. Data were obtained from a standardized portfolio, and 
from endoscopy procedure reports and electronic medical records.
Patient experiences
Patient experiences were measured by using a questionnaire that was filled in after the 
colonoscopy, at time of discharge from the recovery room. Patients were asked to score 
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the perceived pain and discomfort on a three point scale. Secondly, patients had to rate 
their overall satisfaction with the endoscopic procedure on a 5-point Likert scale. In 
addition, the questionnaire focused on patients` opinion regarding the communicative 
and technical skills of the NE. The last section of the questionnaire determined whether 
patients had a preference for a physician or nurse endoscopist. In addition, patients 
were asked to rate their preference considering waiting time for a NE and hereafter for 
a physician endoscopist to be 2 weeks shorter. Responses had to be given on a 5-point 
Likert scale representing a substantial or moderate preference for a physician endosco-
pist, no preference for a physician or nurse endoscopist, and a moderate or substantial 
preference for a NE, respectively.
Statistical analysis
Descriptive statistics were used to analyze and report the data. The unadjusted cecal 
intubation rate in unassisted and assisted colonoscopies was calculated. Unassisted 
cecal intubation was defined as having completed the cecal intubation, without as-
sistance from the supervising gastroenterologist. Cecal intubation time was defined as 
the time from insertion of the colonoscope into the rectum until identification of the 
cecum. Withdrawal time was the time taken from cecal identification to the time when 
the scope was withdrawn across the anus, including time taken for manoeuvres such 
as polypectomies. Mean withdrawal times were calculated in colonoscopies in which 
no polyps were removed [19]. Adenoma detection rate was defined as the proportion 
of colonoscopies with adenomas. An unassisted colonoscopy was defined as having 
completed the procedure (including all aspects such as cecal intubation, polypectomy) 
without assistance from the supervising gastroenterologist. Binary logistic regression 
was performed to identify variables associated unassistent colonoscopy. Statistical 
analysis was performed using the SPSS 17.0 program (SPSS Inc. Chicago, IL).
reSultS
nurse endoscopistst
Ten out of 94 hospitals in the Netherlands (11%) employed in total 15 nurses perform-
ing colonoscopies. Six hospitals with 10 trained NE were willing to participate in this 
multicenter prospective study. Four hospitals did not participate for reasons of time 
restraints. Baseline NE characteristics are shown in Table 1. Nine out of ten NE were 
female and median age was 43 years (range 35-49). Before the start of the study, NE 
had performed a median number of 528 colonoscopies (range 208-2103). All NE were 
trained to premedicate and sedate (midazolam with or without pethidine/fentanyl). 
However, in one participating hospital with two NE, local prescription stated that the 
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supervising gastroenterologist administered these medications. All were trained to 
remove diminutive polyps (1-5mm). Six NE (60%) were allowed to remove small polyps 
(6-9mm) and to remove polyps with coagulation. None of the NE removed large polyps 
(≥10mm). In addition, none of the NE performed polypectomies in case lifting of the 
polyp with submucosal injection was necessary. NE trained for a specific procedure 
(including to premedicate and sedate, and to remove polyps), performed the procedure 
under indirect supervision of a gastroenterologist.
Patients and procedure characteristics
In total 1000 colonoscopies, 100 consecutive colonoscopies per endoscopist, were 
evaluated in 1000 patients. Patient and procedure characteristics are shown in table 2. 
Mean patient age was 56 years (SD±15), 55% of the patients were women, and 96% of 
colonoscopies were performed in patients with ASA risk score I or II. 91% of patients 
received conscious sedation with midazolam, with or without pethidine/fentanyl. Bowel 
preparation was excellent or good in 74% of patients. Colonoscopies were performed 
for screening or surveillance in 42%, and for symptomatic indications in 58% of patients.
endoscopic performances
Table 3 summarizes NE endoscopic performances. The un-assisted cecal intubation rate 
was 94% (median 95%, range between NE 88-97%). Overall, cecal intubation rate was 
97%. Mean cecal intubation time was 13 minutes (SD±8), and mean withdrawal time 
was 10 minutes (SD±5). Adenoma detection rate was high with 26.7% (Median 26%, 
range between NE 20-41%). In 229 out of 1000 colonoscopies (23%) (range between 
NE 10-36%) the NE required assistance from the supervising gastroenterologist. More 
Table 1 Baseline characteristics of the Nurse Endoscopists
nurse endoscopists
(n=10)
Age (median, range) 43 years (35-49)
Female gender 9 (90%)
Colonoscopic experience (median, range) 528 (range 208-2103)
Administration of conscious sedation 10 (100%)
Performing polypectomy
• Polyp size
1-5mm 10 (100%)
6-9mm 6 (60%)
≥10mm 0 (0%)
• Method
Without coagulation 10 (100%)
With Coagulation 6 (60%)
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specifically, assistance was required for not reaching the cecum in 60 cases (6%), for 
polypectomy assistence in 72 cases (8%), and for interpretation of the endoscopy find-
ings in 97 cases (12%). There were two serious complications in the 1000 colonoscopies 
(0.2%). One perforation occurred in a patient with polypectomy of a 10 mm large polyp 
that was removed by the supervising gastroenterologist. The patient was successfully 
managed conservatively and recovered uneventful. The other complication involved 
onset of atrial fibrillation at the time of the colonoscopy.
Logistic regression analysis showed that assistance from the supervising gastroenterolo-
gist was significantly more often needed in elderly patients (OR 1.03 [1.02 – 1.05]), and 
in patients with higher ASA risk score (OR 2.71 [1.52 – 4.83]). Patients` gender, the use of 
Table 2. Patient and procedure characteristics
Patients
(n=1000)
Age (mean, SD) 56 years (SD 15)
Female gender 549 (55%)
ASA risk score
- 1 or 2 959 (96%)
- 3 or more 9 (1%)
- Missing 32 (3%)
Referral
- General practitioner 601 (60%)
- Gastroenterology 226 (23%)
- Surgery 100 (10%)
- Internal medicine 43 (4%)
- Other 1 (0%)
- missing 29 (3%)
Indication
- Screening or surveillance 416 (42%)
- Symptomatic 581 (58%)
- missing 3 (0%)
Sedative / analgesic premedication
- Yes 914 (91%)
- No 71 (7%)
- Missing 15 (2%)
Bowel preparation
- Excellent / good 743 (74%)
- Fair 36 (4%)
- Poor / very poor 107 (11%)
- Missing 114 (11%)
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sedative premedication, bowel preparation, the indication for the colonoscopy, and NEs’ 
age, gender, and endoscopic experience were not related with unassisted colonoscopy.
Patient experiences
In total, 734 out of 1000 questionnaires were completed, corresponding with a response 
rate of 73%. 694 out of 734 respondents (95%) were satisfied with the endoscopic pro-
cedure. 420/734 (57%) experienced no pain during the colonoscopy, whereas 236/734 
(32%) experienced moderate and 77/734 (11%) experienced substantial pain. 722 out 
of 734 respondents (98%) were satisfied with the communicative skills, and 698 out of 
734 respondents (95%) were satisfied with the technical skills of the NE. Furthermore, 
530 out of 734 respondents (72%) had no specific preference for a physician or nurse 
endoscopist. However, considering colonoscopy waiting time for a NE and hereafter for 
a physician endoscopist to be 2 weeks shorter, respectively 467/734 (64%) and 454/734 
(62%) of respondent preferred the colonoscopy at a shorter time interval.
diSCuSSiOn
To date nurse endoscopy studies have so far not elucidated performances of NE perform-
ing full colonoscopy. We performed a multicenter prospective study with ten trained 
NE performing in total 1000 colonoscopies. Our results demonstrated that trained NE 
perform colonoscopies according to the international recognized quality standards, 
Table 3 Endoscopic performances
Patients
(n=1000)
Performance per endoscopist
(median, range)
Cecal intubation rate (unadjusted)
- Un-assisted 940 (94%) 95% (88 – 97)
- Total 971 (97%) 98% (95 – 100)
Cecal intubation time (Mean) 13.1 min, SD 8.3 11.3 min (8.3 – 19.9)
Withdrawal time (Mean)* 10.2 min, SD 5.1 10.1 min (6.6 – 15.2)
Adenoma detection rate, % (95%CI) 26.7% (23.3 – 29.1) 26% (20 – 41)
Assistance supervisor required
- Yes 229 (23%) 22% (10 – 36)
- No 712 (71%)
- Missing 59 (6%)
Complications
- Perforation 1 (0.1%)
- Cardiorespiratory complication 1 (0.1%)
* only colonoscopies without intervention
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with high patient satisfaction. Cecal intubation rate was over 90%, and adenoma detec-
tion rate was high, 26.8%. Two complications occurred in 1000 colonoscopies (0.2%). 
In only about a quarter of colonoscopies, NE required assistance from the supervising 
gastroenterologist for an advice, or assistant with introduction of the endoscope or the 
polypectomy. Assistance was significantly more frequently needed in older patients, and 
in patients with higher ASA risk score. Patients` gender, the use of sedative premedica-
tion, bowel preparation, the indication for the colonoscopy, and NEs’ age, gender, and 
endoscopic experience were not related with requiring assistance. Focusing on patient 
experiences, the vast majority of patients (95%) were satisfied with the endoscopic 
procedure. In addition, the majority of patients (72%) had no specific preference for a 
physician or nurse endoscopist. Of note, patients generally preferred the colonoscopy at 
a shorter time interval. These data support the use of NE.
Our results are in agreement with previous studies which showed that NE are competent 
in performing gastroscopy and sigmoidoscopy [14,15,20]. In addition they are in line 
with findings of previous studies towards nurse performed colonoscopy. To date, three 
small single center reports were identified. Koornstra et al suggested that nurses can ef-
fectively be trained to become competent colonoscopists. Two nurses and one first year 
fellow were compared through a colonoscopy training protocol with 150 colonoscopies 
per trainee. Their results showed that nurse and fellow achieved similar cecal intubation 
rates, cecal intubation times, complication rates, and patient satisfaction during training. 
Withdrawal times and adenoma detection rates were not measured. More importantly, 
performance was not formally assessed as end points were only measured during train-
ing under direct supervision [16]. Maslekar et al suggested that there are no differences 
in patient satisfaction in lower gastrointestinal endoscopy between non-physician and 
physician endoscopists. In total, 503 procedures, including 332 colonoscopies were 
evaluated. Examinations were performed by one of two non-physician endoscopists 
or by a physician endoscopist. Results showed that there were no differences in terms 
of patient satisfaction, In addition, there were no differences in completion rates and 
complications. However, other established quality indicators for technical performance 
were not measured [18]. Finally, Limoges-Gonzalez et al suggested that properly trained 
NE perform screening colonoscopies as safely, accurately and satisfactory as physician 
endoscopists. 150 subjects referred for screening colonoscopy were randomized to a 
colonoscopy performed by either a NE (n=1) or by one of two physician endoscopists. 
Results of this small single center study showed that NE had significantly higher ad-
enoma detection rates, and greater patient satisfaction [17].
In some Western countries, NE already contribute significantly to the gastrointestinal 
endoscopy services. In the Netherlands, ten out of 94 hospitals (11%) employed in 
Paul BW.indd   33 25-Apr-13   15:52:23 PM
34 Chapter 3
3
total 15 nurses performing colonoscopies. The Individual Health Care Professionals Act 
authorizes these nurses to perform gastrointestinal endoscopies, provided they achieve 
the standards of a competent endoscopist, as laid down in the regulations of the Dutch 
Society of Gastroenterology. These regulations are endorsed and the adherence to it is 
regularly checked in all Dutch centers by means of on-site quality assurance assessments 
by the Dutch Society of Gastroenterologists. Nurse endoscopy is also widely practiced 
in the United Kingdom. The British Society of Gastroenterology (BSG) supports the role 
of NE for various endoscopic procedures. In 2005 over 200 NE were practicing in the 
UK. Their number had significantly increased in only five years [21-23]. Furthermore, 
the American Society for Gastrointestinal Endoscopy (ASGE) allows nurses to perform 
screening sigmoidoscopies [24]. In 2002 6.1% of all screening sigmoidoscopies in the 
USA were performed by non-physician endoscopists [25].
It is generally recognized that endoscopic capacity is insufficient for the increased 
demand resulting from CRC screening programs. However, the shortage in endoscopic 
capacity depends on the chosen modality of primary screening, the target population, 
population adherence with the screening program, and finally the surveillance protocol 
[8-12]. In addition, the magnitude of the problem varies between different regions [7,12].
There are several potential solutions to gain endoscopic capacity. Appropriate utiliza-
tion of endoscopy services would free capacity. Studies have shown that 23% to 39% of 
all gastrointestinal endoscopies are being performed for inappropriate indications or at 
inappropriate surveillance intervals when compared to guidelines [26-28]. On the other 
hand, endoscopic capacity can be increased by training of additional gastroenterolo-
gists. However, GI fellowship positions are expensive. In addition, it has been suggested 
that the need for additional gastroenterologists should be balanced with the need for 
other aspects of gastroenterology care [8]. A more effective way to increase endoscopic 
capacity would be to increase productivity and efficiency of currently available gastro-
enterologists [9,29]. This could be accomplished in a strategy where multiple NE perform 
endoscopies in a properly supervised setting.
There are several important issues to the establishment of nurse endoscopy. Guidelines 
for NE training and criteria to maintain procedural competence after training should 
be defined. These guidelines should rely on available studies regarding the endoscopic 
skills of NE and be comparable with that of fellows. This in recognition of the educational 
differences between nurse and physician. Several professional groups already devel-
oped such guidelines [30]. If competence has been demonstrated, individual endosco-
pists should be credentialed by local institutions to perform the respective endoscopic 
procedures. In addition, clear job descriptions must define the scope of practice and 
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specific responsibilities for NE and their supervisors. In the Netherlands for example, 
rules for health care professionals are set by the Individual Health Care Professionals 
Act (Wet BIG). This act authorizes nurses to perform specific delegated tasks, provided 
they are competent in performing the task as determined by training and accreditation, 
and perform the task under a pre-specified level of supervision. In the specific case of 
prescribing sedation, nurses were not allowed to prescribe these medications. However, 
NE were allowed to administer and control the sedative/analgesic medications with a 
physician’s order, under indirect supervision, provided they do so according to the stan-
dards set in the Dutch guideline for non-anesthesiologists on sedation and/or analgesia 
at remote locations. Nurses trained and judged competent for performing a specific 
procedure, will be judged accordingly, and are personally responsible for the procedure. 
However, it is the responsibility for local institutions to define these responsibilities. 
These will also clarify the medico-legal implications and effectiveness for the proposed 
strategy where gastroenterologists supervise NE. Furthermore, reimbursement policies 
should be adapted to facilitate a cost-effective and adequate reimbursement. Overcom-
ing these issues will allow introduction of NE in the gastrointestinal endoscopic service.
As gastroenterologists are to train and supervise NE, it is important that they support 
nurse endoscopy. We previously noted that gastroenterologists are in general positive 
towards an important albeit restricted role for NE [23]. Potential benefits are recognized 
but concerns are expressed, including adequacy of training, quality, patient acceptance, 
and interference with training for gastroenterology fellows. Dealing with these concerns 
is a prerequisite for institutions considering to introduce NE. Recognizing these issues 
and concerns, the decision to introduce NE should be based mainly upon competence 
in endoscopy and endoscopic demand as dictated by local conditions.
A limitation of our study was that the performances of NE were not compared with the 
performances of physician endoscopists. However, we recently performed a representa-
tive and comprehensive survey on performance of Dutch gastroenterologists perform-
ing colonoscopy. In 12 Dutch endoscopy departments, a total of 4800 consecutive 
colonoscopies performed by 116 endoscopists were assessed for endoscopic quality. 
Overall, cecal intubation rate was 92%, and adenoma detection rate was 24% [31]. These 
results are according to the international recognized quality standards and comparable 
with the findings in our study. At the moment a prospective observational study is being 
performed to evaluate differences between nurse and physician endoscopists in quality 
of colonoscopies and patient experiences. Results are expected at the end of 2012.
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In conclusion, our results demonstrated that NE perform colonoscopies according to 
the international recognized quality standards, with high patient satisfaction. These 
findings advocate the involvement of NE in colonoscopy.
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AbStrACt
Background and Aims: To compare endoscopic quality and safety between nurse and 
physician performed colonoscopy and to evaluate cost differences.
Methods: 7 nurses and 8 physicians without endoscopic experience were enrolled in 
this multicenter prospective comparative cohort study. Each endoscopist obtained 
endoscopic training, including a minimum of 100 performed colonoscopies. Next, 
each endoscopist performed 135 consecutive colonoscopies, which were evaluated for 
endoscopic quality and safety. Colonoscopies were performed under supervision of a 
gastroenterologist. Descriptive statistics, multilevel and cost minimization analysis were 
performed.
Results: All endoscopists completed the training and then performed 1946 of 2025 
colonoscopies (96%), which were assessed for quality and safety; 866 were performed 
by NE and 1080 by PE. Mean patient age was 57yrs in both groups (p=0.69), and about 
half were women (p=0.76). Endoscopic quality and safety were comparable between NE 
and PE. Overall cecal intubation rates were 95% and 93% (p=0.38, including procedures 
where assistance from a supervisor was necessary) and mean withdrawal times were 
10.4 and 9.8min (p=0.44), respectively. Adenoma detection rates were 27%, and compli-
cation rates 0.5% for both. In both groups, unassisted cecal intubation rates gradually 
increased with the amount of colonoscopies performed, from 70% for NE and 74% for 
PE in the beginning until 89% and 86% at the end of the assessment period. Considering 
a strategy where one gastroenterologist supervised three NE, personnel costs declined 
from €58.60 to €41.22 per colonoscopy (-€17.38).
Conclusions: In a supervised setting, NE perform colonoscopies according to quality and 
safety standards, and comparable to PE. However, NE require more supervision, but may 
substantially reduce costs.
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intrOduCtiOn
In the Western world colorectal cancer (CRC) is the third most commonly diagnosed 
cancer and the second leading cause of cancer-related death [1]. Screening for CRC with 
removal of adenomatous polyps has been shown to reduce the incidence of and mortal-
ity due to CRC [2,3]. This has led to the introduction of CRC screening programs in many 
countries over the past years [4,5].
Irrespective of the chosen strategy, any CRC screening program considerably increases 
the demand for colonoscopy [6-8]. However, in many countries colonoscopy capacity is 
insufficient to meet this projected increase in demand, which serves as a barrier to CRC 
screening [7-11].
Training of nurse endoscopists (NE) may expand colonoscopy capacity. The introduction 
of NE training and performance in gastrointestinal endoscopy was first reported in 1977 
by the Mayo clinic, USA [12]. Subsequent studies showed that NE were competent in 
performing upper gastrointestinal endoscopy as well as sigmoidoscopy. These results 
formed the basis to advocate the involvement of NE in gastrointestinal endoscopy ser-
vices in several Western countries [13-16]. Their involvement in endoscopy subsequently 
expanded to colonoscopy [17].
To date, however, only four studies have investigated the quality of colonoscopies 
performed by NE [17-20]. These studies suggested that NE could become competent 
colonoscopists, but they were mostly small, single center studies, and did not compare 
the performance of NE with physician endoscopists (PE). Therefore, the aim of the pres-
ent study was to compare endoscopic quality, safety and costs of nurse- and physician-
performed colonoscopy in a large multicenter prospective cohort study.
methOdS
Hospitals in the Netherlands, interested in introducing NE, were invited to participate 
in this multicenter prospective cohort study. In the Netherlands, the health care pro-
fessionals law authorizes nurses to be trained in and perform specific delegated tasks, 
provided that the tasks are performed according to quality standards and under pre-
specified supervision [21]. Each participating hospital recruited at least one NE from 
the pool of nurses working at their GI endoscopy unit. In addition, consecutive PE were 
enrolled from the group of GI fellows who after two-year training in internal medicine 
entered the four-year course of gastroenterology training under the auspices of the 
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Departments of Gastroenterology and Hepatology of the Erasmus University Medical 
Center Rotterdam, and the Maastricht University Medical Center. The study took place 
between September 2008 and April 2012.
At baseline, NE and PE included in the study were without any endoscopic experience. 
All enrolled endoscopists obtained formal training in gastrointestinal endoscopy, ac-
cording to the standards as laid down in the regulations of the Dutch Society of Gastro-
enterology [22]. The trainees were trained in and assessed for theoretical knowledge and 
technical skills. Basic hand skills were trained with use of computer simulators (Olympus 
and Symbionix) [23,24]. Further technical skills were acquired by hands-on teaching 
from acknowledged gastrointestinal endoscopy trainers. Initially trainees only observed 
procedures, followed by attempting the less demanding aspects of gastrointestinal 
endoscopy, and gradually progressing to performing the entire procedure including 
specific interventions. The trainees performed upper and lower GI endoscopies, includ-
ing a minimum of 100 colonoscopies each. All training endoscopies were performed 
under direct supervision of a gastroenterologist, meaning that the gastroenterologist 
was present in the endoscopy room during the whole procedure. Instructions were 
given and interference and assistance took place when necessary.
Colonoscopies were performed with or without moderate sedation (using midazolam 
and/or an opioid) at discretion of the patient and endoscopist, using the preparation 
and techniques according to the protocols of the participating hospitals as endorsed 
by the Dutch Society of Gastroenterology. In case of NE, the sedative medication was 
administered by the supervising gastroenterologist. In addition, all endoscopists were 
trained to remove diminutive (1-5mm) and small polyps (6-9mm). Large polyps (≥10mm) 
were removed by the supervising gastroenterologist.
After completion of the basic training, including at least 100 colonoscopies, each 
endoscopist next performed 135 consecutive colonoscopies, which were assessed for 
endoscopic quality and safety. These 135 colonoscopies per endoscopist were used to 
compare the performance of NE and PE. At this stage, the endoscopists were expected 
to progress through stages of decreasing supervision, extending from the initial com-
plete direct supervision to a phase of partial indirect supervision. In the latter phase, the 
supervising gastroenterologist was not necessarily constantly present in the room, but 
was present at the endoscopy unit and on-demand immediately available for technical 
or diagnostic advice and assistance.
Colonoscopies were performed in patients referred for diagnostic colonoscopy and 
included asymptomatic and symptomatic patients. Patients were in order of appearance 
allocated to colonoscopy lists by secretarial staff of the endoscopy units, and the NE 
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and PE were randomly assigned to a program without any prior insight in the details of 
the program and the patients on the list. Patients under 18 years of age or specifically 
referred for therapeutic procedures were allocated to expert endoscopist programs. 
All patients underwent a pre-procedural assessment by a physician who was familiar 
with the patient and the procedure. The physical status of each patient was assessed 
using the American Society of Anesthesiologists’ (ASA) classification system. Patients 
were informed about the indication, preparation, the endoscopy itself and possible 
interventions, including its benefits, risks and limitations, as well as possible alternatives. 
Informed consent was obtained, including consent for performing the colonoscopy 
with or without sedative/analgesic medication. Immediately prior to the procedure, the 
endoscopist performed a brief reassessment of the referred patient.
endoscopist, patient and procedure characteristics
At baseline, endoscopists’ demographics were obtained, including age, gender and 
education. All endoscopists were required to maintain an accurate portfolio of their 
experience. All performed procedures were recorded on standardized data collection 
forms, supplemented by validated evaluation sheets and endoscopic skill assessment 
forms that have been recently validated in a similar form [25]. Furthermore, data were 
obtained from endoscopy procedure reports and electronic medical records. The follow-
ing patient and procedure characteristics were assessed: patient demographics, referrer, 
indication for the procedure, premedication, bowel preparation, reach of the procedure, 
whether cecal intubation was successful or not, cecal intubation time, withdrawal time, 
number of detected lesions, need for supervision with cecal intubation or any interven-
tion such as polypectomy, and complications. Information on histology of lesions that 
were removed during endoscopy was obtained from pathology reports.
Statistical analysis
Descriptive statistics were used to analyze and report the data. The unadjusted cecal 
intubation rates for unassisted and overall colonoscopies were calculated. Unassisted 
cecal intubation was defined as having reached the cecum without assistance from 
the supervising gastroenterologist. Cecal intubation time was defined as the time 
from insertion of the colonoscope into the rectum until identification of the cecum. 
Withdrawal time was the time needed from cecal identification to withdrawal of the 
endoscope from the anus. Mean withdrawal times were calculated with exception for 
the time needed for removal of polyps [26]. Polyp and adenoma detection rates were 
defined as the percentage of colonoscopies with polyps and adenomas, respectively. 
Generalized estimating equations were used for a 2-level analysis to compare outcome 
parameters in two groups while correcting for the individual endoscopists nested within 
the groups. In a generalized linear mixed model (specifically a form of logistic regression 
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for longitudinal data) we compared cecal intubation rates between the two groups over 
the course of the assessment period. In this model, the variables Group and ‘Number of 
Endoscopies’ were used as independent variables and the interaction between these 
two was also included. The variable ‘Number of Endoscopies’ was modeled by a 3-degree 
spline with 2 knots. Correlations between the repeated measurements of endoscopists 
were accounted for by including a random intercept term for the endoscopists. In addi-
tion, cost minimization analyses were performed to compare personnel costs between 
PE colonoscopy and a scenario where one gastroenterologist supervises multiple NE. 
Cost calculations were based on 234 workable days per year, 8 working hours per day, 
30 minutes examination time per colonoscopy, 3744 performed colonoscopies per unit 
per year, using the salary schemes of university hospitals in the Netherlands. Since we 
focused on cost differences, we ignored any non-personnel costs (material, investments, 
maintenance expense and overhead costs), which we assumed similar in both scenarios. 
The primary outcome measurement of the study was adenoma detection rate. The 
sample size was chosen based on a presumed adenoma detection rate of 25%. In order 
to yield 80% power to detect a 5% decrease in adenoma detection (1-sided Type I error 
of 5%), we aimed to recruit 6 NE and 6 PE performing 862 colonoscopies per group.
Statistical analysis was performed using the SPSS 20 program (SPSS Inc. Chicago, IL). The 
Institutional Review Boards of the participating centers approved the study.
reSultS
endoscopist, patient and procedure characteristics
A total of 7 NE and 8 PE from eight Dutch hospitals participated in this study. Most NE 
were female (M/F 1/6), whereas PE had an even sex ratio (M/F 4/4). Median age was 32 
years for both NE and PE (range 27.4-49.2 for NE, and 29.7-34.6 for PE, p=0.87). All endos-
copists completed the training including a minimum of 100 performed colonoscopies 
each. The number of upper and lower GI endoscopies that were performed during the 
training period by NE and PE are shown in Table 1.
Table 1. Upper and lower GI endoscopies performed by nurse (NE) and physician endoscopists (PE) during the training period
ne
(n=7)
Pe
(n=8)
p-value*
Endoscopies during training period, median (range)
- gastro/sigmoidoscopies 0 (0-203) 358 (211-559) <0.01
- colonoscopies 100 (100-200) 114 (100-200) 0.54
* Mann-Whitney-U test
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After having finished the training part of the study, each endoscopist performed 135 
colonoscopies in consecutive patients who were planned for colonoscopy. In total, 1946 
out of the planned 2025 colonoscopies (135 consecutive colonoscopies per endoscopist) 
(96%) were performed and assessed for competency, the remaining 79 (4%) colonosco-
pies were not performed as one NE dropped out. Of the 1946 colonoscopies, 866 (45%) 
were performed by NE and 1080 (55%) by PE. Patient and procedure characteristics of 
the colonoscopies are shown in Table 2. Patients’ age and sex were similar in both groups 
with a mean patient age of 57 years and an approximate 50/50 male/female distribu-
tion. However, NE patients had more often ASA risk scores I or II (respectively 98% vs. 
91% (p<0.01)), and were more often referred for symptomatic indications (respectively 
76% vs. 66% (p<0.01). Moderate sedation with midazolam, with or without pethidine/
fentanyl, was administered to 99% of the NE patients and to 92% of the PE patients 
(p<0.01). Bowel preparation was excellent or good in approximately 80% of the NE and 
PE patients (p=0.29).
Table 2. Patient and procedure characteristics
ne (n=7)
(866 colonoscopies)
Pe (n=8)
(1080 colonoscopies) p-Value
Mean age (years, SD) 57.4 (15.0) 57.1 (16.3) 0.69
Female gender, n (%) 431 (50%) 545 (51%) 0.76
ASA risk score n= 521 n=727 <0.01
- ASA 1 or 2 510 (98%) 664 (91%)
- ASA 3 or more 11 (2%) 63 (9%)
Referral n=704 n=975 <0.01
- Gastroenterology 368 (52%) 594 (61%)
- Internal medicine 27 (4%) 117 (12%)
- Surgery 20 (3%) 44 (5%)
- General practitioner 130 (19%) 92 (9%)
- Other 159 (23%) 128 (13%)
Indication n=843 n=1050 <0.01
- Surveillance 200 (24%) 358 (34%)
- Symptomatic 643 (76%) 692 (66%)
Sedative premedication 99% 92% <0.01
- Midazolam, mean dose (mg, SD) 5.0 (±2.1) 5.3 (±1.8) <0.01
- Fentanyl, mean dose (mg, SD) 0.057 (±0.0.34) 0.074 (±0.028) <0.01
- Pethidine, mean dose (mg, SD) 43.7 (±11.5) 42.5 (±12.3) 0.31
Bowel preparation n=710 n=905 0.29
- Excellent/good/fair 558 (79%) 731 (81%)
- Poor/very poor 152 (21%) 174 (19%)
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endoscopic performances
Table 3 summarizes the endoscopic performance of the endoscopists in both groups. 
Endoscopic quality and safety were comparable between NE and PE. Overall cecal 
intubation rates (including those procedures where assistance from a supervisor was 
necessary) were 95% and 93% (p=0.38), mean cecal intubation times were 12.2 and 11.5 
minutes (p=0.52), and mean withdrawal times were 10.4 and 9.8 minutes, respectively 
(p=0.44). During the assessment period, in both groups unassisted cecal intubation 
rates gradually increased with the amount of colonoscopies performed (Fig.1). In both 
NE and PE, the spline significantly increased from the beginning of the assessment 
period towards the end (p<0.01). Compared to PE, NE had lower unassisted cecal in-
tubation rates in the beginning of the assessment period (70% vs. 74% resp.) and also 
during the assessment they lay below those of the physicians. Towards the end, the 
two splines converged (89% for NE and 86% for PE respectively), while the differences 
between the two groups were at no point in time statistically significant. A total of 1597 
lesions were detected during the assessment period. Polyp detection rates were 45% for 
colonoscopies performed by NE and 44% for colonoscopies performed by PE (p=0.82). 
Adenoma detection rates were 27% for both NE and PE (p=0.93). Mean adenoma num-
ber per positive procedure was 2.2 and 1.8 for NE and PE, respectively (p=0.14). Details 
on histology of all removed polyps are shown in Table 4. Complication rates were 0.5% 
(4/866) and 0.5% (5/1080) (p=0.99), respectively. There were four complications (0.5%) 
in 859 colonoscopies performed by NE; three patients suffered from rectal bleeding fol-
Table 3. Endoscopic quality parameters of 1946 procedures performed during the assessment period.
ne (n=7)
(866 colonoscopies)
Pe (n=8)
(1080 colonoscopies) p-Value
Cecal intubation rate n=804 n=1023
- unassisted 77% 88% 0.04
n=849 n=1058
- overall 95% 93% 0.38
Mean cecal intubation time, min (SD) 12.2 (5.8) 11.5 (6.0) 0.52
Mean withdrawal time, min (SD)* 10.4 (4.2) 9.8 (4.3) 0.44
Polyp detection rate, % 45% 44% 0.82
Adenoma detection rate, % 27% 27% 0.93
Carcinoma detection rate, % 3% 4% 0.68
Complications n=859 n=1079
- No complications 855 (99.5%) 1074 (99.5%) 0.99
- Bleeding 3 (0.3%) 1 (0.1%)
- Perforation 0 (0.0%) 0 (0.0%)
- Cardiorespiratory 1 (0.1%) 4 (0.4%)
*Only colonoscopies without intervention and without needed supervision included in calculation
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Figure 1. Learning curves (incl. 95% confidence intervals) of NE (red) and PE (blue). The graphs represent the unassisted cecal-
intubation rates in the course of the assessment period.
Table 4. Polyps detected during colonoscopy.
ne (n=7)
(866 colonoscopies)
Pe (n=8)
(1080 colonoscopies) p-Value
No polyp detected 55% 56% 0.82
Polyp detected 45% 44%
Total number of polyps detected 660 937
Not removed, n (%) 38 (6) 45 (5) 0.40
Removed, n (%) 622 (94) 892 (95) 0.43
Histology of removed polyps
Normal tissue, n (%) 44 (7) 67 (8)
Pseudopolyp, n (%) 14 (2) 20 (2)
Hyperplastic polyp, n (%) 176 (28) 254 (28)
Adenoma, n (%) 343 (55) 466 (52)
Carcinoma, n (%) 4 (1) 2 (0)
Other, n (%) 10 (2) 10 (1)
Missing, n (%) 31 (5) 73 (8)
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lowing polypectomy and one patient developed bradycardia and hypotension during 
colonoscopy. Five complications (0.5%) occurred in the group of PE; one patient had 
a postpolypectomy bleeding and four patients developed cardiorespiratory symptoms 
during colonoscopy resulting in two admissions (one patient developed atrial fibrilla-
tion with heart failure and another patient severe tachycardia >170/min).
Costs
Costs were compared in a cost-minimization analysis comparing colonoscopy performed 
by either a gastroenterologist or by a NE (in a scenario where 1 gastroenterologist super-
vises 3 NE). Calculations were based on a mean duration of 30 minutes per colonoscopy 
and accounted for salary costs of the endoscopist and of one assisting endoscopy nurse. 
Mean personnel costs (€) declined from €58.60 to 41.22€ per procedure (-€17.38) in the 
NE scenario (Table 5).
Table 5. Cost minimization scenario to compare personnel costs between colonoscopy performed by a gastroenterologist and a 
scenario where one gastroenterologist supervises three NE. Cost calculations were based on 234 workable days per year, 8 working 
hours per day, 30 minutes examination time per colonoscopy, and 3744 performed colonoscopies per unit per year.
Gastroenterologist nurse endoscopist
Gastroenterologist (9614*12*1.08*1.37)/ 3744 = €45.59 (45.59/3 NE)= €15.20
Nurse endoscopist n.a. (2744*12*1.08*1.37)/ 3744 = €13.01
Nurse (2744*12*1.08*1.37)/ 3744 = €13.01 €13.01
Sum €58.60 41.22€
diSCuSSiOn
This is the first prospective comparative study evaluating the quality of colonoscopies 
performed by NE and PE in a large setting. We found that NE perform colonoscopy with 
similar quality and safety as PE in terms of generally accepted quality measures such 
as unadjusted cecal intubation rates, adenoma detection rates, withdrawal times, and 
complication rates. Unadjusted cecal intubation rates were 95% in NE and 93% in PE, 
mean withdrawal times were 10.4 and 9.8 minutes, adenoma detection rates were 27% 
for both, and complication rates were 0.5% and 0.5%, respectively. However, during the 
assessment period, unassisted cecal intubation rates of the NE lay slightly below those 
of the PE most of the time, but in both groups they gradually increased with the amount 
of colonoscopies performed and reached 89% (NE) and 86% (PE) at the end of the as-
sessment. Furthermore, we found that in a scenario of one gastroenterologist supervis-
ing three NE, personnel costs in NE performed colonoscopies were lower compared to 
colonoscopies performed by a gastroenterologist.
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So far, only a few studies have compared endoscopic quality of NE performing full 
colonoscopy with those of PE [18-20]. These small, single center studies showed that 
adequate training of NE to perform full colonoscopy yielded similar quality and similar 
low complication rates when compared with colonoscopies performed by PE. Prior data 
from our group evaluating quality and safety of NE performed colonoscopy in 10 NE per-
forming 1000 colonoscopies in a multicenter cohort study showed that NE performed 
colonoscopies according to the international recognized quality standards, including 
unassisted cecal intubation rate over 90% and an adenoma detection rate of about 27% 
[17]. These studies however did not assess the progress and performance of NE and PE 
in the same setting and with the same formal endoscopy training. The present study 
therefore directly compared colonoscopy performed by NE and PE with similar training 
and performance in the same patient categories and same setting.
The results obtained in the current study are mostly in agreement with those of the pre-
vious studies and show that NE are competent in performing colonoscopy, although a 
regular training program does not yet bring them at a level that fully meets international 
guideline recommendations and standards. In the Netherlands, a minimum number of 
200 colonoscopies are requested for certification for colonoscopy (Dutch Society of 
Gastroenterology). At the end of the assessment period (thus after having finished at 
least 235 colonoscopies), unassisted cecal intubation rates of both NE and PE were still 
slightly below the required 90%. However, overall (unassisted and assisted) cecal intuba-
tion met the international standards [27] rates in both groups. These results support that 
NE can similar to PE and with the same training learn to perform diagnostic colonoscopy 
at a high quality and safety level.
It is generally recognized that capacity of physician endoscopists will be insufficient for 
the increased demand for endoscopic procedures, resulting from the introduction of 
CRC screening programs. In the Netherlands, a nationwide CRC screening program will 
be implemented in 2013 - 2018, to cover the age group from 55 to 75 years. Screen-
ing will be performed by means of biennial fecal immunochemical testing (FIT) and 
it is estimated that this will lead to a yearly demand for an approximate 80.000 extra 
colonoscopies. It is important to consider the impact of a nationwide CRC screening 
program on endoscopic capacity and manpower to avoid unacceptable waiting times. 
There are several possibilities to approach this problem. First, indications to perform en-
doscopy should be appropriate. Studies have shown that 23% to 39% of all gastrointes-
tinal endoscopies are being performed for inappropriate indications or at inappropriate 
surveillance intervals when compared to guidelines [28-30]. Then, training additional PE 
can increase capacity. However, fellowship positions are expensive and time-consuming 
and thus do not yield sufficient endoscopic capacity within short time. The training of 
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NE to perform colonoscopies in a supervised setting may be an effective and cost-saving 
alternative. A recent survey performed among Dutch gastroenterologists showed that 
gastroenterologists are positive towards a significant role for NE, with restriction to 
diagnostic and minimally invasive therapeutic procedures [31].
There are several important issues to the establishment of nurse endoscopy. Guidelines 
for NE training and criteria to maintain procedural competence after training need to 
be defined. These guidelines should rely on available studies regarding the endoscopic 
skills of NE and be comparable with that of fellows. For that purpose, the Dutch Society 
of Gastroenterologists has developed such guidelines together with a one-year training 
program, among others based on the results of the current study. Once competence has 
been demonstrated, national institutions should credential individual endoscopists to 
perform the respective endoscopic procedures. In addition, clear job descriptions must 
define the scope of practice and specific responsibilities for NE and their supervisors. 
This will also clarify the legal implications and effectiveness for the proposed strategy 
where gastroenterologists supervise multiple NE. Furthermore, reimbursement policies 
should be adapted to facilitate a cost-effective and adequate reimbursement. Overcom-
ing these issues will allow introduction of NE in the gastrointestinal endoscopic service.
The main limitation of this study is that patients were not randomized between NE and 
PE, but on a consecutive basis assigned to the next endoscopy list. Furthermore, dur-
ing training, PE simultaneously performed a fair number of gastroscopies, while most 
NE did not, which probably led to differences in training. On the other hand, the main 
advantage of this study is the large size of our cohort of endoscopists and the large 
number of colonoscopies that were performed and evaluated.
In summary, this study provides support that with the same training and supervision, 
NE perform colonoscopy with similar quality and safety as PE. However, NE have slightly 
lower unassisted intubation rates, and during training need more assistance by a su-
pervisor. Our results demonstrate that NE can perform colonoscopies with high quality 
standard but might require longer training periods or a broad training including both 
upper and lower GI endoscopies. Our data are generilisable to all patients with ASA I 
and II who are undergoing diagnostic colonoscopy. They advocate the involvement of 
NE in colonoscopy. The introduction of nurse endoscopy is relevant in many countries in 
terms of colonoscopy demand and health care costs.
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AbStrACt
Aim: To determine the inter-observer variation in the histological diagnosis of colorectal 
polyps.
Methods and results: 440 polyps were randomly selected from a colorectal cancer (CRC) 
screening program. Polyps were first evaluated by a general (324 polyps) or expert 
(116 polyps) pathologist, and subsequently re-evaluated by an expert pathologist. 
Conditional agreement was reported and inter-observer agreement was determined by 
using Kappa statistics. In 421/440 polyps (96%) agreement for the non-adenomatous 
or adenomatous nature was obtained, corresponding with a very good kappa of 0.88. 
Differentiating adenomas as non-advanced and advanced obtained consensus in 
266/322 adenomas (83%), with a moderate kappa of 0.58. For the non-adenomatous 
or adenomatous nature, both general and expert pathologists, and expert pathologists 
among each other, showed very good agreement (kappa-values (95%CI); 0.89(0.83-
0.95) and 0.86(0.73-0.98), respectively). Categorizing adenomas as non-advanced and 
advanced showed moderate agreement between general and expert pathologists, and 
between expert pathologists (kappa-values (95%CI); 0.56(0.44-0.67) and 0.64(0.43-0.85), 
respectively).
Conclusions: General and expert pathologists demonstrate very good inter-observer 
agreement for differentiating non-adenomas from adenomas, but only moderate agree-
ment for non-advanced and advanced adenomas. The considerable variation in the 
interpretation of advanced histology suggests that more objective criteria are required 
for risk stratification in screening and surveillance guidelines.
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intrOduCtiOn
Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the second 
leading cause of cancer-related death in the Western world [1,2]. The detection and 
removal of adenomatous colorectal lesions reduces CRC incidence and mortality [3,4]. 
Advanced adenomas have a greater likelihood of malignant transformation and devel-
opment of metachronous adenomas than non-advanced adenomas [5]. Conversely, 
hyperplastic lesions carry minimal risk of adenoma occurrence [6,7].
Histopathological diagnosis of colorectal lesions plays a crucial role in patient manage-
ment and surveillance after polypectomy. Postpolypectomy surveillance guidelines 
stratify patients in high and low risk according to their risk of an advanced neoplasia 
at subsequent colonoscopy. Current guidelines recommend a surveillance colonoscopy 
3 years after removal of an advanced adenoma or 3 or more non-advanced adenomas, 
and 5 to 10 years after removal of 1 or 2 non-advanced adenomas [8]. Histopathologic 
assessment of colorectal polyps is also vital in screening for CRC. Advanced adenomas 
are considered the surrogate marker for CRC risk and are a primary end-point of screen-
ing [9]. As many countries have implemented or are preparing nation-wide CRC 
screening [10,11], accurate pathologic assessment of colorectal lesions is of paramount 
importance.
Concern has been raised about the reproducibility of the histological interpretation, 
between general and between expert gastrointestinal pathologists [12,13]. The aim of 
the present study was to evaluate inter-observer variation in histological diagnosis of 
colorectal polyps detected in a CRC screening program. Furthermore, inter-observer 
variation was assessed between general and expert gastrointestinal pathologists, and 
between expert gastrointestinal pathologists.
methOdS
Study setting
As part of a Dutch population-based randomized screening trial (CORERO I trial) we ran-
domly selected 440 polyps. The CORERO I study has been described in detail elsewhere 
[14]. In brief, this randomized population-based trial compared uptake and diagnostic 
yield of guaiac based fecal occult blood test (g-FOBT), fecal immunochemical test (FIT) 
and flexible sigmoidoscopy (FS) screening for CRC. Recruitment took place between No-
vember 2006 and November 2007. In total 15,011 individuals aged 50-74 years old were 
1:1:1 randomized to be invited for gFOBT, FIT or FS screening. Participants with a positive 
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gFOBT (Hemoccult II) or FIT (OC-Hemodia Latex; ≥50 nanogram haemoglobin/ml) were 
referred for colonoscopy. Participants to FS screening were referred for colonoscopy 
when one of the following criteria was met: presence of a polyp with a diameter ≥10 
mm; an adenoma with villous histology (≥25% villous) or high-grade dysplasia; three or 
more adenomas; ≥20 hyperplastic polyps; or invasive CRC.
Sampling procedure and organization
All polyps detected at FS or colonoscopy were removed. The inter-observer evaluation 
was conducted on 440 randomly selected polyps; 324 polyps were detected at colonos-
copy in participants with a positive gFOBT or FIT (FOBT polyps), and 116 polyps were 
detected during FS (FS polyps). For initial pathological evaluation, the 324 FOBT polyps 
were evaluated by a general pathologist (n=23) and the 116 FS polyps were evaluated 
by an expert gastrointestinal pathologist (n=1). Subsequently, all 440 samples were 
blindly re-evaluated by an (one of two) expert gastrointestinal pathologist.
Criteria for pathologic classification
The WHO classification was adopted to classify the selected polyps as non-adenomatous 
or adenomatous [15]. Adenomatous lesions were further categorized according to his-
tologic type, degree of dysplasia, and absence or presence of infiltrating carcinoma. In 
agreement with the National Polyp study and other studies on CRC screening, we defined 
a tubular adenoma as an adenoma with less than 25% villous component. Adenomas 
having a 25% - 75% or more than 75% villous component, were defined as tubulo-villous 
and villous adenoma, respectively[16-21]. The degree of dysplasia was classified as low 
or high grade dysplasia. According to the revised Vienna criteria, patients with intramu-
cosal carcinoma or carcinoma in situ were classified as having high-grade dysplasia [22]. 
Advanced adenomas were defined as adenomas of at least 10mm, or as adenomas with 
villous histology (≥25%villous) or with high-grade dysplasia. CRC was defined as inva-
sion of malignant cells beyond the muscularis mucosa and was classified according to 
the TNM classification [23-25].
Statistical analysis
Descriptive statistics were used to analyze and report the data. Conditional agreement 
was reported using percentages. Inter-observer agreement was determined by using 
Cohen κ statistics, which are widely used mathematical coefficients adjusting for agree-
ment by chance alone. A value of 0 indicates no agreement better than what would be 
expected by chance alone. Values of < 0.21, 0.21–0.40, 0.41–0.60, 0.61–0.80 and >0.80 
correspond to poor, fair, moderate, substantial and very good inter-observer agreement, 
respectively. In addition, as the kappa coefficient is influenced by the prevalence and 
bias of ratings, the prevalence-index and bias-index was calculated. A prevalence effect 
Paul BW.indd   58 25-Apr-13   15:52:24 PM
Histopathological diagnosis of colorectal polyps 59
5
exists when the proportion of agreements on the positive classification differs from that 
of the negative classification. If the prevalence index is high (prevalence of a positive 
rating is very high or very low), chance agreement is also high and kappa is reduced. 
A bias effect exists if each observer rates a differing proportion of cases as positive. If 
the disagreement is asymmetrical, bias is large and kappa is higher than when bias is 
low or absent [26]. The histological diagnoses were categorized as non-adenomatous 
or adenomatous. Adenomatous lesions were further categorized as non-advanced or 
advanced based on histology only. For further categorization, the degree of dysplasia 
was classified as low or high grade dysplasia. Adenomas were categorized as tubular 
adenoma or adenoma with ≥25% villous component. In addition, inter-observer agree-
ment was calculated for polyps that were represented by diminutive (1-5mm), small 
(6-9mm), and large (≥10mm) polyps. The size of each polyp was measured during the 
endoscopy using an open biopsy forceps with 7mm span. Furthermore, inter-observer 
agreement between a general and expert pathologist, and between expert pathologists 
was assessed. Statistical analysis was performed using the SPSS 15.0 program (SPSS Inc. 
Chicago, IL). A two-sided p-value of < 0.05 was considered statistically significant.
reSultS
Polyp characteristics
In total, 440 colorectal polyps were evaluated. The polyp characteristics as described by 
the initial pathologist are shown in Table 1. The initial pathologists identified 106 non-
adenomas (24%) and 334 adenomas (76%). Ninety-five of the 440 polyps (22%) were 
classified as advanced adenomas. The FOBT polyps were, as compared to the FS polyps, 
significantly larger and more often of advanced histology.
inter-observer variation
Table 2 shows the agreement among pathologists on histological diagnosis of colorectal 
polyps. In 421 out of 440 polyps (96%) agreement for the non-adenomatous or adeno-
matous nature of polyps was obtained. More specifically, pathologists agreed on 99 
non-adenomas and 322 adenomas, corresponding with a very good kappa-value of 
0.88 (95% CI; 0.83 - 0.94) (prevalence-index 0.51, bias-index 0.01). Categorizing the 322 
adenomatous lesions as non-advanced and advanced obtained consensus in 266 ad-
enomas (83%). There was consensus for 198 non-advanced adenomas and 68 advanced 
adenomas. Inter-observer agreement for classifying adenomas as non-advanced or 
advanced was moderate with kappa 0.58 (95% CI; 0.48 – 0.68) (prevalence-index 0.40, 
bias-index 0.01).
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Table 1. Polyp characteristics as defined by the initial pathologist
total
(n=440)
n (%)
fObt polyps
(n=324)
n (%)
fS polyps
(n=116)
n (%) p-value
Polyp
- Non-adenomatous 106 (24%) 84 (26%) 22 (19%)
0.13
- Adenomatous 334 (76%) 240 (74%) 94 (81%)
Adenoma
Non-advanced/advanced*
- non-advanced 239 (54%) 161(50%) 78 (67%)
0.004
- advanced 95 (22%) 79 (24%) 16 (14%)
Dysplasia
- Low-grade dysplasia 307 (70%) 219 (68%) 88 (76%)
0.48
- High-grade dysplasia 27 (6%) 21 (6%) 6 (5%)
Histologic type
- Tubular 245 (56%) 166 (51%) 79 (68%)
0.002- Tubulovillous/villous 82 (19%) 70 (21%) 12 (10%)
- Carcinoma in situ or intramucosal 7 (2%) 4 (1%) 3 (3%)
Polyp size**
- Diminutive (1-5mm) 224 (51%) 135 (42%) 89 (77%)
<0.001- Small (6-9mm) 87 (20%) 68 (21%) 19 (16%)
- Large (≥10mm) 129 (29%) 121 (37%) 8 (7%)
*based on histology only.
**The size of each polyp was measured during the endoscopy
Table 2. Inter-observer agreement between pathologists
n Agreement, n (%) k-values (95% Ci)
Non-adenomatous / Adenomatous polyps 440 421 (96%) 0.88 (0.83 - 0.94)
- ≤5mm 224 212 (95%) 0.89 (0.82 - 0.95)
- >5mm 216 209 (97%) 0.84 (0.72 - 0.96)
- <10mm 311 295 (95%) 0.88 (0.82 - 0.94)
- ≥10mm 129 126 (98%) 0.85 (0.67 - 1,02)
Non-advanced / Advanced adenoma 322 266 (83%) 0.58 (0.48 – 0.68)
- ≤5mm 134 123 (92%) 0.48 (0.22 - 0.74)
- >5mm 188 143 (76%) 0.52 (0.39 - 0.64)
- <10mm 205 179 (87%) 0.53 (0.37 - 0.69)
- ≥10mm 117 87 (74%) 0.48 (0.33 - 0.64)
Low grade / High grade dysplasia* 322 304 (94%) 0.62 (0.46 – 0.79)
Tubular / Tubulo-villous and villous adenoma 315 259 (82%) 0.55 (0.44 – 0.66)
* including carcinoma in situ and intramucosal carcinoma.
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Among the 322 adenomatous polyps, agreement for low or high grade dysplasia was 
obtained in 304 polyps (94%). There was consensus for 287 low grade and 17 high-grade 
dysplastic lesions. Due to the large prevalence-index, inter-observer agreement was 
only moderate with kappa 0.62 (95% CI; 0.46 – 0.79) (prevalence-index 0.86, bias-index 
0.01). Focussing on the high grade dysplastic lesions; pathologists agreed that five le-
sions had intramucosal carcinoma or carcinoma in situ. On another two lesions there 
was disagreement in the classification; high grade dysplastic adenoma vs. intramucosal 
carcinoma/carcinoma in situ. No carcinoma invading the submucosa was observed in 
any of the samples. Categorizing the 315 adenomas (without intramucosal carcinoma 
or carcinoma in situ) as tubular adenoma or as adenoma with ≥25% villous component, 
obtained consensus in 259 polyps (82%). Pathologists agreed on 203 tubular adeno-
mas and 56 adenomas with ≥25% villous histolology. Inter-observer reproducibility 
for grading villousness was moderate with a kappa-value of 0.55 (95% CI; 0.44 – 0.66) 
(prevalence-index 0.47, bias-index 0.01). Overall consensus for the non-adenomatous 
/ adenomatous nature, and histological type and grade of dysplasia of adenomas was 
obtained in 336/440 polyps (76%).
influence of polyp size on inter-observer variation
The level of agreement between pathologists was not affected by polyp size (Table 2). 
Within each size category (1-5mm, 5-9mm and ≥10mm), reproducibility was very good 
for differentiating between non-adenomas and adenomas (with a kappa-value ranging 
from 0.84 and 0.89), and reproducibility was moderate for categorizing adenomas as 
non-advanced and advanced (with a kappa-value ranging from 0.48 and 0.53).
inter-observer variation between general and expert pathologists, and 
between expert pathologists
Inter-observer agreement in the classification of colorectal polyps was similar between 
general and expert pathologists on the one hand, and between two expert pathologists 
on the other hand (Table 3). Both groups showed very good agreement in categorizing 
polyps as non-adenomatous and adenomatous. The general and expert pathologists 
agreed on 310/324 polyps (96%), including 80 non-adenomatous and 230 adenomatous 
polyps. The two expert pathologists agreed on 111/116 polyps (96%); 19 non-adeno-
matous and 92 adenomatous polyps. Kappa-values were 0.89 (95% CI; 0.83 - 0.95) and 
0.86 (95% CI; 0.73 – 0.98), respectively. Of note, the polyps evaluated by the general 
and expert pathologist had, as compared to the polyps evaluated by the two expert 
pathologists, a lower prevalence-index. The bias-index was low for both groups.
Furthermore, both groups showed moderate agreement for categorizing adenomas 
as non-advanced or advanced. The general and expert pathologist agreed on 184/230 
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adenomas (80%), including 128 non-advanced and 56 advanced adenomas. The expert 
pathologists agreed on 82/92 adenomas (89%); 70 non-advanced and 12 advanced 
adenomas. Kappa-values were 0.56 (95% CI; 0.44 - 0.67) and 0.64 (95% CI; 0.43 – 0.85), 
respectively. Of note, the adenomas evaluated by the general and expert pathologist 
had a lower prevalence-index as compared to the adenomas evaluated by the two 
expert pathologists. The bias-index was low for both groups.
diSCuSSiOn
This study describes the inter-observer variation in the histological diagnosis of colorec-
tal polyps detected in a CRC screening program. Our data demonstrated very good 
inter-observer agreement in categorizing polyps as non-adenomatous or adenomatous 
(kappa-value 0.88). This level of concordance was better than observed by Yoon et al 
[13], but consistent with other studies [12,27-30]. Our results showed that inter-observer 
agreement was only moderate for differentiating between non-advanced and advanced 
adenomas (kappa-value 0.58). The inconsistency of pathologists in differentiating be-
tween non-advanced and advanced adenomas was more frequently based on grading 
and assessing villousness than on grading of dysplasia. Of note however, kappa-values 
were moderate for both; grading villous histology (kappa-value 0.55), and due to a large 
prevalence index also moderate for grading dysplasia (kappa-value 0.62). Our results 
are in line with other studies also showing a poor to moderate level of agreement 
for classifying the proportion of villous component and the grade of dysplasia. These 
studies however did not specifically investigate agreement after stratifying adenomas 
as non-advanced and advanced [12,13,27-32]. Furthermore, we found that the level of 
agreement between pathologists was not affected by polyp size.
Table 3. Inter-observer agreement between general (GP) and expert pathologists (EP), and between expert pathologists (EP`s).
Combined GP and eP eP and eP
Non-adenomatous / Adenomatous
- K-value (95% CI) 0.88 (0.83 - 0.94) 0.89 (0.83 - 0.95) 0.86 (0.73 - 0.98)
- Prevalence-index 0.51 0.46 0.62
- Bias-index 0.01 0.02 0.01
Non-advanced/Advanced adenoma
- K-value (95% CI) 0.58 (0.48 - 0.68) 0.56 (0.44 - 0.67) 0.64 (0.43 - 0.85)
- Prevalence-index 0.40 0.31 0.63
- Bias-index 0.01 0 0.02
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Our results showed that the inter-observer agreement in categorizing of colorectal 
polyps was similar between general and expert pathologists one the one hand, and be-
tween expert pathologists on the other hand. This is in agreement with previous studies 
on the histopathological interpretation of colorectal polyps [12,13,27-32]. In addition, in 
other fields of pathology it was also found that expert pathologists are just as likely to 
disagree as general pathologists [33-35].
Our data confirm that the classification of advanced adenoma is subject to inter-
observer variation [12,13,27-32]. This has major clinical implications for patients with 
diminutive (1-5mm) and/or small (6-9mm) adenomas, as large adenomas (≥10mm) 
are already classified as advanced adenomas. A recent systematic review reported that 
diminutive and/or small adenomas were found to contain advanced histology in 12.5% 
of screened subjects in an average risk population [36]. Possible misclassification might 
therefore occur in a large proportion of patients. This has major implications for the 
decision on surveillance interval, as current guidelines also base the time interval for a 
surveillance colonoscopy on the presence of advanced adenoma [8]. Misclassification of 
low risk patients may therefore lead to inadequate colonoscopic surveillance, whereas 
misclassification of high risk patients may result in unnecessary invasive and costly colo-
noscopies with some associated morbidity. Furthermore, postpolypectomy surveillance 
represents 22% of all colonoscopies [37]. In an era of limited endoscopy resources, it is 
of paramount importance to have objective criteria for risk stratification of subjects with 
adenoma for recommendations on surveillance interval [38-43].
Furthermore, it has been suggested that the current postpolypectomy surveillance 
guidelines have limited predictability for advanced adenoma recurrence [44]. A risk 
profile based on cumulative findings from multiple previous colonoscopies might better 
stratify patients in high and low risk than the adenoma findings from the most recent ex-
amination [45]. In addition, recent evidence indicates that other factors than histological 
diagnosis, are stronger associated with the development of metachronous advanced 
adenomas. A pooled multivariate analysis of postpolypectomy patients showed that 
after four years of follow-up, the risk of metachronous advanced colorectal neoplasia 
was strongly associated with the number, size, and location of prior adenomas, as well 
as patient age. In the multivariate analysis, the presence of villous histology was only 
modestly associated, and the grade of dysplasia was not associated with metachronous 
advanced neoplasia [46]. In agreement with our findings, some postpolypectomy 
surveillance guidelines (e.g. the Dutch revised adenoma surveillance guideline and the 
United Kingdom NHS Bowel Cancer Screening Program) do not use histological subtyp-
ing as indicator for surveillance interval, and only use size and number of adenomas 
[47,48]. Guidelines that do use the presence of advanced adenoma for risk stratification 
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may reconsider these criteria given the subjectivity, the poor reproducibility, and the 
uncertainty on the role as a predictor of future risk.
In addition, the level of inter-observer variability needs to be considered in the context 
of the outcome of current studies and colorectal cancer screening programs. Colorectal 
cancer screening programs rely on advanced adenoma as intermediate endpoint.
Our study has some limitations. First, in total twenty-three general and two expert 
pathologists reviewed the pathology specimens. This was done with the deliberate 
purpose to resemble a situation as seen in a nation-wide colorectal cancer screening 
program. In such a setting many general pathologists review the biopsy specimens, 
whereas only a few expert pathologists will review selected specimens, either for quality 
assurance or because of uncertain diagnosis. Our results will therefore closely reflect 
outcomes of a population-based nation-wide screening program.
Second, we should emphasize that the level of agreement between the two expert 
pathologists might be underestimated. The two expert pathologists had, as compared 
to the general and expert pathologist, higher prevalence-indexes for the differentiation 
between non-adenomas and adenomas, and between non-advanced and advanced 
adenomas (table 3). These higher prevalence-indexes predisposed to diagnose or not to 
diagnose adenomas and advanced adenomas. This increased the chance of agreement, 
and subsequently suppressed the kappa-values.
In conclusion, this study demonstrated that pathologists have a very good inter-observ-
er agreement for differentiating between non-adenomatous and adenomatous polyps, 
while the agreement is only moderate for non-advanced and advanced adenomas. 
Agreement is comparable between general and expert pathologists on the one hand, 
and between expert pathologists on the other hand. The considerable variation in the 
interpretation of advanced histology suggests that more objective criteria are required 
for risk stratification in screening and surveillance guidelines.
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AbStrACt
Aim: To determine the diagnostic test characteristics and inter-observer variation of 
pathology features for identifying MSI-H colorectal cancer (CRC).
Methods and Results: Six pathologists blindly evaluated 177 CRC for the presence of 
MSI-H associated pathology features. Inter-observer agreement was determined by 
using Kappa-statistics. In the first random 88/177 cases, mucinous carcinoma, tumor-
infiltrating lymphocytes (TIL) and Crohns-like infiltrate (CLI) were the best discriminators 
between MSI-H and microsatellite stable CRC (OR 5.6 (95%CI 1.7-19), 5.4 (1.8-17) and 3.5 
(1.1-11), respectively), with high specificity (89%-91%). The sensitivities for MSI-H, how-
ever, were low (31-41%). In addition, inter-observer agreement was moderate for TIL and 
CLI (kappa 0.38 and 0.48, respectively), but very good for mucinous carcinoma (kappa 
0.86). Interpretation of overall histopathology as suggestive for MSI-H performed better 
than any individual feature; OR 15 (5.2-44), and AUC 0.79. However, inter-observer agree-
ment was moderate (kappa 0.53). In the second set, TIL and CLI were scored according 
to updated scoring systems. Although both remained the best individual discriminators, 
test characteristics and inter-observer agreement did not improve.
Conclusions: MSI-H pathology features have moderate accuracy for identifying MSI-H 
CRC, and are identified with moderate inter-observer agreement. These findings high-
light the limitations of clinical strategies, such as the revised Bethesda guidelines, which 
incorporate the MSI-H associated pathology features in their strategy to identify persons 
with LS.
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intrOduCtiOn
Lynch syndrome (LS) is an autosomal dominant inherited disorder caused by mutations 
in mismatch repair (MMR) genes. LS is the commonest form of hereditary colorectal 
carcinoma (CRC) and is responsible for approximately 3% of all CRC cases [1,2]. Addition-
ally, LS is associated with extra-colonic cancers, mostly endometrial carcinoma [3]. Early 
detection of LS is important since colonoscopic surveillance can reduce overall mortality 
by about 65% [4].
Diagnosis of LS is complicated by the absence of a pre-morbid phenotype. To improve 
the efficiency of recognizing LS, various guidelines were published to select cases for 
germline mutation analysis, including a molecular diagnostic work-up of tumors, guided 
by clinical and pathological criteria. The combination of the revised Bethesda guidelines 
and MSI testing and/or IHC analysis is nowadays the most widely applied strategy for the 
identification LS carriers [5], although other effective approaches have been proposed 
as well [2,6-11].
The revised Bethesda guidelines for lynch syndrome recommend for molecular testing; 
all CRC in patients diagnosed before age 50 years, and all CRC diagnosed in patients 
between ages 50 and 59 years with the presence of one or more pathology features 
known to be associated with high microsatellite instability (MSI-H), namely; mucinous 
differentiation, signet ring cell pattern, medullary pattern, presence of tumor-infiltrating 
lymphocytes (TIL), and presence of Crohn’s-like infiltrate (CLI) [5,8]. However, concern 
has been expressed about the reproducibility of the histological interpretation of these 
MSI-H related pathology features. The aim of this study was to determine the diagnostic 
test characteristics of MSI-H associated pathology features for identifying MSI-H CRC, 
and to evaluate the inter-observer variation in the histological diagnosis of these pa-
thology features.
methOdS
Study setting
In total, 177 CRC cases were selected from a multicenter population based prospective 
study in CRC patients ≤ 70 years (LIMO-study). The LIMO-study has been described in 
detail elsewhere [10]. In brief, this study evaluated the yield of routine molecular analy-
sis for LS in consecutive CRC patients ≤ 70 years and patients with advanced colorectal 
adenoma ≤ 45 years. Recruitment took place between May 2007 and September 2009. 
In total, 1117 CRC cases were included. All tumor specimens were routinely analyzed 
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for MSI, and immunohistochemical MMR protein expression (MLH1, MSH2, MSH6 and 
PMS2). Microsatellite unstable tumors without MLH1 expression were also evaluated for 
MLH1 promotor methylation and somatic BRAF mutations. Tumors were classified as 
either: (a) likely caused by LS; (b) sporadic microsatellite-unstable; or (c) microsatellite-
stable (MSS). Patients likely to have LS were referred to the department of clinical 
genetics for counseling, eventually followed by germline mutation analysis. Molecular 
analyses revealed a MSI-H profile in 121 out of 1117 CRC (10.8%).
Sampling procedure and organization
The evaluation was conducted on 177 CRC cases: all 77 MSI-H cases that were available 
for the agreement analysis, completed with 100 randomly selected MSS cases. Coded 
hematoxylin and eosin slides, one representative of each case, were blindly evaluated 
by six pathologists (four general and two expert gastrointestinal pathologists). Each sec-
tion was cut from the same routine formalin-fixed and paraffin-embedded (FFPE) tissue 
block as had been used for molecular testing. None of the pathologists had knowledge 
of patient cancer family history or any results of MSI or immunohistochemistry tests 
done on the tumor. First, all pathologists blindly evaluated a random subset of 88 of 
the 177 CRC. Second, a meeting was organized to review the scoring of the different 
MSI associated pathology features with a focus on discrepant results. In addition, up-
dated scoring systems were introduced. Third, the pathologists blindly evaluated the 
remaining 89 CRC. Glass slides were completely digitized to produce whole slide images. 
Whole slide imaging is a relative new technique that uses computerized technology to 
scan and convert pathology specimen glass slides into digital images which are then 
accessible for viewing using a monitor and viewing software. We used the Hamamatsu 
Nanozoomer Digital Pathology (NDP) slide scanner (Hamamatsu, Japan) at a resolution 
of 40X which is comparable to 400X magnification on a microscope. The obtained files 
were uploaded into a secured internet environment to which the pathologists had ac-
cess. NDP Slideviewer software; NDP server and NDP View, provided by Hamamatsu, 
were used. Images shown in this paper are sections of the files exported from the digital 
slides. At the discussion meeting, concern was expressed about the possible influence 
of the digitized technology on the study outcome. In response, glass slides from 17 
randomly selected CRC from the first set of CRC were additionally sent to all pathologists 
for agreement analysis. Pathologists were unaware that these CRC had been included in 
the first CRC set.
Criteria for pathologic classification
The WHO classification was adopted to classify the CRC [12]. Adenocarcinomas were 
assessed for degree of differentiation, histology subtype (mucinous differentiation, 
signet ring cell pattern and medullary pattern), presence of TIL and presence of CLI. The 
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grade of differentiation was based on the least differentiated area but excluded dedif-
ferentiation or tumor budding at the invasive margin. Poor differentiation was defined 
as a tumor with at least some glandular structures but with the glands highly irregular 
and difficult to discern. Mucinous carcinoma was defined as at least 50% of the tumor 
area comprising secretory mucin. Signet ring cell carcinoma was defined as at least 50% 
of the tumor composed of signet ring cells. Medullary carcinoma was defined as a tumor 
that was poorly differentiated or undifferentiated and composed of masses of cells 
circumscribed with a well-circumscribed margin and a marked lymphocytic infiltrate 
that was both peri-tumoral and intra-tumoral. Tumor-infiltrating lymphocytes (TIL) were 
scored as present, when there were at least five intra-epithelial lymphocytes in at least 
one high-power field and at least 10 high-power fields had been thoroughly searched. A 
Crohn’s-like lymphocytic (CLI) reaction was scored as present, when at least four nodular 
lymphoid aggregates were counted in a low power field beyond the advancing edge 
of the tumor and generally within the subserosa or mesenteric fat. In addition, each 
pathologist was asked to indicate whether, based on the histopathological features, the 
specific case should be tested for MSI (yes or no).
In the second CRC set and the glass slides, TIL and CLI were scored according to up-
dated scoring systems. We aimed to simplify and improve the categorization of these 
features, and thereby to improve the diagnostic test characteristics for differentiating 
between MSI-H and MSS CRC, and to improve the inter-observer agreement. The pres-
ence of TIL were scored as; not assessable/ negative/ low/ moderate or substantial, in 
at least one high-power field and at least 10 high-power fields had been thoroughly 
searched. Likewise, the presence of CLI were scored as; not assessable/ negative/ low/ 
moderate or substantial, in a low-power field. To clarify the different scoring possibilities, 
wallpapers were made and send to all pathologists (Figure 1 and 2).
mSi analysis
MSI analyses were performed on DNA derived from microdissected FFPE tumor tissue, 
using a panel of five markers, as previously described [13]. Tumors with more than one 
unstable marker were categorized as MSI-H. Those with one or no unstable marker were 
categorized MSS.
Statistical analysis
Descriptive statistics were used to analyze and report the data. Histopathological fea-
tures were scored as present, when the majority of pathologists agreed on the presence 
of the feature. Diagnostic test characteristics (i.e. sensitivity, specificity, and diagnostic 
odds ratio) used MSI-status as the reference. Conditional agreement was reported using 
percentages. Inter-observer agreement was determined by using Cohen’s kappa (κ), 
which is a widely used statistical measure that adjusts for agreement by chance alone. 
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Figure 1. Updated scoring system for tumor-infiltrating lymphocytes. The presence was scored as; negative/low/moderate or substantial
Figure 2. Updated scoring system for Crohn’s-like lymphocytic reaction. The presence was scored as; negative/low/moderate or substantial
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A κ value of 0 indicates no agreement better than what would be expected by chance 
alone. Values of < 0.21, 0.21–0.40, 0.41–0.60, 0.61–0.80 and >0.80 correspond to poor, 
fair, moderate, substantial and very good inter-observer agreement, respectively [14]. 
The updated scoring systems developed for TIL and CLI were further categorized. The 
features were scored as present, when their presence was classified as moderate or sub-
stantial. Comparisons between expert and general pathologists and the first and second 
round were evaluated by using receiver operating characteristic (ROC) curves analysis, 
and calculation of the area under the curve (AUC). Statistical analysis was performed 
using the SPSS 20.0 program (SPSS Inc. Chicago, IL). A two-sided p-value of < 0.05 was 
considered statistically significant.
reSultS
CrC characteristics
In total, 170 out of 177 cases (96%) were evaluable for the agreement analysis: 83 in 
the first and 87 in the second round. Seven patients (4%) were excluded due to low 
quality hematoxylin and eosin slides. In the first and second set, 39 out of 83 (47%), and 
33 out of 87 (38%) were MSI-H CRC (p=0.23, Table 1). Table 2 shows the inter-observer 
agreement between pathologists on evaluating the pathology features. Diagnostic test 
characteristics for predicting MSI-H status and inter-observer agreement in evaluating 
the MSI-H related pathology features are summarized in Table 3.
Table 1. CRC characteristics as described by the majority of pathologists
total
(n=170)
n (%)
round 1
(n=83)
n (%)
round 2*
(n=87)
n (%)
Poor differentiation 46 (27%) 23 (28%) 23 (26%)
Mucinous carcinoma 30 (18%) 18 (22%) 12 (14%)
Signet ring cell carcinoma 4 (2%) 3 (4%) 1 (1%)
Medullary carcinoma 4 (2%) 2 (3%) 2 (2.3%)
Tumor-infiltrating lymphocytes present 31(18%) 21 (25%) 10 (12%)
Crohns like lymphocytic reaction present 37(22%) 17 (21%) 20 (23%)
One or more features suggestive for MSI present 95 (56%) 48 (58%) 47 (54%)
MSI test request 52 (31%) 38 (46%) 14 (16%)
MSI status
- MSI-H 72 (42%) 39 (47%) 33 (38%)
- MSS 98 (58%) 44 (53%) 54 (62%)
* Updated scoring systems for tumor-infiltrating lymphocytes and Crohns-like infiltrate in second round
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first set
Twenty-three out of 83 cases (28%) were categorized as poorly differentiated by the 
majority of observers. Poor differentiation was found in 36% of MSI-H (14 of 39) and 20% 
of MSS (9 of 44) tumors (Odds ratio 2.2, p=0.12). Inter-observer agreement for classifying 
differentiation was moderate (median kappa 0.42 (range 0.05-0.63). Signet ring cell car-
cinoma and medullary carcinoma were identified in only 5 out of 83 CRC (7%), without 
a significant difference between molecular subtypes, and with respectively substantial 
and fair inter-observer agreement. Mucinous carcinoma was diagnosed in 18 out of 83 
CRC (22%). TIL and CLI were present in 21 (25%) and 17 (21%) out of 83 CRC, respectively. 
Mucinous carcinoma, TIL and CLI were the best individual discriminators for distinguish-
ing MSI-H and MSS cancers (Odds ratio 5.6 (95% CI 1.7-19), 5.4 (95% CI 1.8-17) and 3.5 
(95% CI 1.1-11), respectively), with high specificity (91%, 89% and 89%, respectively). The 
sensitivities for MSI-H, however, were low (36%, 41% and 31% respectively). In addition, 
inter-observer agreement was only fair to moderate for TIL and CLI (median kappa 0.38 
Table 2. Paired inter-observer agreement between pathologists on the histological diagnosis of MSI-H related pathology features
round 1
(n=83)
n (%)
round 2*
(n=87)
n (%)
Differentiation (poor/other)
- Agreement; median, range 60 (73%), 43-68 (51-82%) 60 (69%), 50-71 (57-82%)
- Kappa-value; median, range 0.42 (0.05-0.63) 0.38 (0.15-0.57)
Mucinous carcinoma (yes/no)
- Agreement; median, range 79 (95%), 77-83 (93-100%) 81 (93%), 77-85 (89-98%)
- Kappa-value; median, range 0.86 (0.78-1.00) 0.73 (0.63-0.90)
Signet ring cel carcinoma (yes/no)
- Agreement; median, range 80 (96%), 78-83 (94-100%) 87(100%), 85-87 (98-100%)
- Kappa-value; median, range 0.65 (0.26-1.00) 1.00 (0.49-1.00)
Medullary carcinoma (yes/no)
- Agreement; median, range 75 (90%), 73-82 (88-99%) 85 (98%), 83-87 (95-100%)
- Kappa-value; median, range 0.39 (0.11-0.70) 0.66 (0.32-1.00)
Tumor infiltrating lymfocytes (yes/no)
- Agreement; median, range 59 (71%), 48-68 (58-82%) 73 (84%), 66-78 (76-90%)
- Kappa-value; median, range 0.38 (0.22-0.48) 0.42 (0.18-0.68)
Crohns like infiltrate (yes/no)
- Agreement; median, range 66 (80%), 60-71 (72-86%) 72 (83%), 63-79 (72-91%)
- Kappa-value; median, range 0.48 (0.33-0.63) 0.53 (0.30-0.71)
MSI suspected (yes/no)
- Agreement; median, range 64 (77%), 56-69 (67-83%) 67 (77%), 58-74 (67-85%)
- Kappa-value; median, range 0.53 (0.37-0.65) 0.37 (0.20-0.50)
* Updated scoring systems for tumor-infiltrating lymphocytes and Crohns-like infiltrate in second round
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(range 0.22-0.48) and 0.48 (range 0.33-0.63), respectively), but very good for mucinous 
carcinoma (median kappa 0.86 (range 0.78-1.00)). Lesions with at least one histologic 
feature present were about 6 times more likely to be MSI-H than those with none of 
the predictive features (p<0.001). Subjective interpretation of overall histopathology as 
suggestive for MSI-H, performed better than any individual feature; the odds ratio was 
15.0 (95% CI 5.2-44), with sensitivity of 77%, specificity of 82%, and an area under the 
curve (AUC) of 0.79. However, inter-observer agreement was moderate (median kappa 
0.53 (range 0.37-0.65)).
When only considering the two expert pathologists, the diagnostic value of the 
MSI-H associated pathology features did not improve. The histopathological features 
were found in comparable proportions, and with comparable predictive values and 
inter-observer agreement. Of note, the predictive value of TIL for identifying MSI-H 
CRC improved but inter-observer agreement was moderate and the diagnostic value of 
overall histopathology for predicting MSI-status remained unchanged (Table 3).
Second set
After the consensus meeting, the diagnostic test characteristics for predicting MSI-H sta-
tus, and inter-observer agreement in evaluating MSI-H associated pathology features, 
did not improve. Comparable with the first set, 23 out of 87 cases (26%) were classified 
as poorly differentiated, poor differentiation did not differentiate between MSI-H and 
MSS CRC (Odds ratio 1.8, p=0.25), and inter-observer agreement was fair (median kappa 
0.38 (range 0.15-0.57)). In addition, the small numbers of signet ring cell and medul-
lary carcinoma were without a significant difference between molecular subtypes, and 
were scored with very good and substantial inter-observer agreement, respectively. As 
compared with the first round, the histologic value of mucinous carcinoma decreased. 
Mucinous carcinoma was identified in 12 out of 87 CRC (14%), without a significant 
predictive value (Odds ratio 1.8, p=0.35), and with moderate inter-observer agreement 
(median kappa 0.73 (range 0.63-0.90)). Furthermore, the updated scoring method for 
TIL and CLI did not improve the test characteristics and the inter-observer agreement. 
TIL and CLI were scored as present, in 10 (12%) and 20 (23%) out of 87 CRC, respectively. 
Although both features remained the best individual discriminators (Odds ratio 8.3 (95% 
CI 1.6-42.1) and 3.3 (95% CI 1.2-9.2), respectively), the test characteristics and agreement 
did not improve. For CLI, the AUC remained 0.61, and inter-observer agreement stayed 
moderate (median kappa 0.53 (range 0.30-0.71)). The inter-observer agreement in clas-
sifying TIL also remained moderate (median kappa 0.42 (range 0.18-0.68)) but the AUC 
decreased from 0.65 to 0.60. Lowering the cut-off for scoring TIL present, did increase the 
proportion of CRC with TIL, and increase sensitivity for MSI-H to 94%, however, specific-
ity dropped till 32%. The AUC of TIL with a lower cut-off was 0.63. As the diagnostic value 
of TIL decreased, the AUC of at least one or more features suggestive for MSI-H present, 
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also decreased from 0.70 to 0.65. Furthermore, the value of the subjective interpretation 
of overall histopathology decreased; the AUC decreased from 0.79 to 0.64, sensitivity 
dropped from 77% to 33% (p<0.01), and the inter-observer agreement was only fair 
(median kappa 0.37 (range 0.20-0.50)).
Glass slides
Exploring the 17 randomly selected CRC with a light microscope did not influence the 
level of agreement. Comparable to the digitized CRC, histopathological features were 
found in comparable proportions, and with comparable inter-observer agreement 
(Table 4 and Table 5). Numbers were too small to detect a significant diagnostic value of 
overall histopathology for predicting MSI-status (Odds ratio 7.33, p=0.12, respectively).
Table 4. CRC characteristics as described by the majority of the pathologists on digital and glass slides
digital slides round 1
(n=17)
n (%)
Glass slides*
(n=17)
n (%)
Poor differentiation 4 (24%) 6 (35%)
Mucinous carcinoma 1 (6%) 2 (12%)
Signet ring cell carcinoma 0 1 (6%)
Medullary carcinoma 0 0
Tumor-infiltrating lymphocytes present 5 (29%) 2 (12%)
Crohns like lymphocytic reaction present 4 (24%) 5 (29%)
One or more features suggestive for MSI present 9 (53%) 11 (65%)
MSI test request 4 (24%) 3 (18%)
MSI status
- MSI-H 5 (29%) 5 (29%)
- MSS 12 (71%) 12 (71%)
* Updated scoring systems for tumor-infiltrating lymphocytes and Crohns-like infiltrate on glass slides
diSCuSSiOn
This paper describes the diagnostic test characteristics and the inter-observer variation 
of MSI-H associated pathology features for identifying MSI-H CRC. Our data demon-
strated that mucinous carcinoma, TIL and CLI were the best individual discriminators 
for distinguishing between MSI-H and MSS CRC. However, each of these characteristics 
had a moderate predictive performance (AUC of 0.63, 0.65 and 0.60, respectively). In 
addition, inter-observer agreement was only moderate for TIL and CLI (median kappa 
0.38 and 0.48, respectively), but very good for mucinous carcinoma (median kappa 
0.86). CRC with at least one histologic feature were about six times more likely to be 
MSI-H than those with none of the predictive features (p<0.001). In addition, subjec-
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tive interpretation of the overall histopathological appearance as suggestive for MSI-H 
performed even better (Odds ratio 15 (95% CI 5.2-44), AUC 0.79). Although combining 
the MSI-H associated histology features improved the diagnostic test characteristics, it 
identified only 80% of MSI-H tumors, and only with moderate inter-observer agreement 
(median kappa 0.53). In addition, evaluation by expert pathologists did not improve 
diagnostic test characteristics and inter-observer agreement. Our results are in line with 
other studies that also showed a low sensitivity and inconsistency between pathologists 
in evaluating the histopathological features [15-17]. One study suggested even lower 
sensitivity as well as poorer reproducibility of the MSI-associated pathology features 
[15]. Others found a somewhat better performance of TIL for identifying MSI-H (sen-
sitivity 81% and 93%, respectively) but at the cost of losing specificity (60% and 62%, 
respectively) and without performing an agreement analysis [16,17].
Table 5. Paired inter-observer agreement between pathologists on the histological diagnosis of MSI-H related pathology features on 
digitized and glass slides
digitized slides round 1
(n=17)
n (%)
Glass slides*
(n=17)
n (%)
Differentiation (poor/other)
- Agreement; median, range 14(82%), 10-16 (59-94%) 13(76%), 11-16/(65-94%)
- Kappa-value; median, range 0.49 (0.05-0.85) 0.49 (0.20-0.88)
Mucinous carcinoma (yes/no)
- Agreement; median, range 16(94%),15-17(88-100%) 16(94%),16-17(94-100%)
- Kappa-value; median, range 0.43 (0.43-1.00) 0.64 (0.64-1.00)
Signet ring cel carcinoma (yes/no)
- Agreement; median, range 16(94%),16-17(94-100%) 17(100%),16-17(94-100%)
- Kappa-value; median, range - -
Medullary carcinoma (yes/no)
- Agreement; median, range 16(94%), 16-17(94-100%) 16(94%),16-17(94-100%)
- Kappa-value; median, range - -
TIL (yes/no)
- Agreement; median, range 12(71%), 7-14(58-82%) 15/(88%),14-17/(82-100%)
- Kappa-value; median, range 0.35 (-0.21-0.47) 0.43 (0.30-1.00)
Crohns like infiltrate (yes/no)
- Agreement; median, range 12(71%), 10-15(59-88%) 13(76%), 10-15/(59-88%)
- Kappa-value; median, range 0.47 (0.05-0.63) 0.55 (0.29-0.76)
MSI suspected (yes/no)
- Agreement; median, range 12 (71%), 7-15(41-88%) 12/(71%),8-16(47-94%)
- Kappa-value; median, range 0.32 (-0.20-0.60) 0.39 (-0.10-0.82)
* Updated scoring systems for tumor-infiltrating lymphocytes and Crohns-like infiltrate on glass slides
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A consensus meeting was organized to discuss and review the findings, with a focus 
on discrepant results. In addition, updated scoring systems were introduced aiming to 
simplify and improve the categorization of TIL and CLI. Unfortunately, diagnostic test 
characteristics and inter-observer agreement did not improve. TIL and CLI remained 
the best individual discriminators, but the diagnostic value was similar (AUC 0.60 and 
0.61, respectively), and inter-observer agreement remained moderate (median kappa 
0.42 and 0.53, respectively). In addition, the diagnostic value of mucinous carcinoma 
decreased (OR 1.8, p=0.35, and median kappa 0.73). Therefore, the diagnostic value of 
overall histopathology for identifying MSI-H also decreased.
Our data confirmed that the MSI-H associated pathology features are subject to limited 
diagnostic performance in the classification of CRC according to their molecular status, 
and that they are identified with moderate inter-observer agreement. These results 
highlight the limitations of clinical strategies, such as the revised Bethesda guidelines, 
which incorporate the MSI-H associated pathology features in their strategy to identify 
persons with LS. More specifically, this concerns CRC patients diagnosed between ages 
50 and 59 years, because patients diagnosed before age 50 years are already recom-
mended for molecular testing [5]. Possible misclassification might therefore occur in 
a large proportion of patients if the revised Bethesda criteria are followed, especially 
because only about 45% of LS patients are diagnosed with CRC before age 50 years [2].
Besides the poor diagnostic performance and subjectivity in evaluating the MSI-H as-
sociated pathology features, the revised Bethesda guidelines have been criticized for 
being too complex [9,18]. In addition, the Bethesda guidelines are poorly implemented 
in clinical practice [19]. Together, this leads to a significant number of patients with LS 
who will remain undiagnosed. There is active debate about the optimal and standard 
approach to screening for MMR deficiency. A variety of strategies have been advocated, 
including mathematical algorithms to predict MMR gene mutation carriers based on 
personal and family history [11]. Other approaches rely heavily on routine tumor mo-
lecular testing of CRC in patients before age 50 years, before age 70 years or advice 
universal molecular testing [2,7,9,10].
We used an enriched high-risk sample to efficiently study diagnostic performance. 
In addition, we used whole slide imaging instead of conventional light microscopes. 
However, as this could have introduced bias, the study was extended with an additional 
agreement analysis on 17 glass slides. Results suggested that the level of agreement 
between a conventional light microscopes and whole slide imaging, was high. These 
results are consistent with other studies [20,21].
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In conclusion, our results demonstrated that the MSI-H associated pathology features 
are subject to limited diagnostic performance in the classification of colorectal tumors 
according to their molecular status, and that they are identified with moderate inter-
observer agreement. These findings highlight the limitations of clinical strategies, such 
as the revised Bethesda guidelines, which incorporate the MSI-H associated pathology 
features in their strategy to identify persons with LS.
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AbStrACt
Objective: to compare autofluorescence endoscopy (AFE) and white light video endos-
copy (WLE) for the differentiation between adenomatous and hyperplastic colorectal 
polyps.
Methods: 79 polyps were evaluated with both WLE and AFE. The polyps were detected 
in a back to back comparative study of WLE with a video colonoscope (CF160, Olympus 
Optical) and AFE using Xillix OncoLife (CF40, Olympus Optical) in patients from Lynch 
syndrome or familial CRC families. Back to back colonoscopy was performed by two 
blinded endoscopists. Lesions were graded as adenomatous or hyperplastic based on 
the macroscopic appearance. During AFE, autofluorescence ratio (AFR) was calculated 
for each polyp. Diagnostic test statistics were calculated by using histopathology as the 
reference value.
Results: Histopathology identified 60 adenomatous and 19 hyperplastic polyps. There 
was no difference in size of adenomas and hyperplastic polyps (mean of 4.9 mm and 
5.6 mm, respectively (p=0.20)). The sensitivity of WLE for identifying adenomas was 
75% with a specificity of 32%. Adenomas had significantly higher AFR compared to 
hyperplastic polyps; mean 0.85 and 0.46, respectively (p<0.001). When using an ROC 
determined AFR cut-off value of 0.45, diagnostic test statistics improved considerably as 
compared to WLE; sensitivity increased from 75% to 93% (p=0.007) and specificity from 
32% to 63% (p=0.10).
Conclusions: AFE has better diagnostic test characteristics than WLE for differentiating 
between adenomatous and hyperplastic colorectal polyps in Lynch syndrome or familial 
CRC patients.
Paul BW.indd   88 25-Apr-13   15:52:31 PM
Comparing autofluorescence and white light video colonoscopy in differentiating colorectal polyps 89
7
intrOduCtiOn
Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the second 
leading cause of cancer-related death in the Western world [1,2]. The detection and re-
moval of adenomatous colorectal lesions reduces CRC incidence and mortality [3,4]. This 
effect has not been documented for hyperplastic polyps. With the exception of large 
right-sided hyperplastic polyps, small hyperplastic polyps do not seem to harbor the risk 
to develop into adenocarcinoma [5,6].
Conventional white light endoscopy has been limited to detecting and categorization 
colorectal lesions on the basis of gross morphological changes. Polypectomy and ad-
ditional histological evaluation are essential and the standard approach to differentiate 
between adenomatous and hyperplastic lesions. The removal of hyperplastic polyps 
incurs additional risks, costs and time. Therefore, it would be useful to differentiate 
between adenomatous and hyperplastic polyps at the time of a colonoscopy. Given the 
fact that around 50% of polypectomies are performed on non-adenomatous polyps [7], 
the benefits of real-time histology will be far reaching.
New endoscopic technologies attempt to optimize diagnostic tissue characterization. 
Autofluorescence endoscopy (AFE) has been considered useful for detecting colorectal 
neoplasms. It has been suggested that autofluorescence endoscopy has the potential 
to differentiate between adenomatous and hyperplastic polyps. Autofluorescence is 
an imaging technique in which the mucosa is illuminated by a short wavelength (blue) 
light. This light stimulates endogenous tissue molecules, to emit longer wavelength fluo-
rescence light which can be captured by sensitive cameras and displayed as fluorescence 
image. Because of differences in endogenous composition among various tissues, auto-
fluorescence can potentially distinguish adenomatous from hyperplastic lesions [8,9].
The aim of the present study was to compare autofluorescence endoscopy (AFE) and 
white light video endoscopy (WLE) for the differentiation between adenomatous and 
hyperplastic colorectal polyps.
methOdS
Study setting
In a back to back comparative study of WLE and AFE, 79 polyps were evaluated with 
WLE and AFE. The study has been described in detail elsewhere [10]. In brief, this study 
compared WLE and AFE for the detection of adenomas in patients with Lynch syndrome 
Paul BW.indd   89 25-Apr-13   15:52:31 PM
90 Chapter 7
7
or familial CRC. In total, 75 patients underwent two colonoscopic examinations in one 
session (figure 1). In the original study design AFE was routinely performed after WLE. 
However, as this could have introduced bias, the study was extended with additional 
Figure 1. Study setting
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patients. These patients underwent back to back endoscopy in a reverse order; AFE 
followed by WLE. The first colonoscopy was performed with either WLE or AFE by an 
experienced endoscopist. During the first colonoscopy, all lesions were left in situ. Im-
mediately after the first endoscopic procedure, the first endoscopist left the endoscopy 
room and a second experienced endoscopist, who was unaware of the results of the 
first endoscopic procedure, performed the second endoscopic procedure with the alter-
native endoscopic method. The involved endoscopists; were experienced, had similar 
adenoma detection rates over the past years as identified from our endoscopy database, 
and alternated with respect to the type of endoscopy performed in this study (WLE or 
AFE). In case lesions had been detected during the first endoscopy but missed during the 
second, the colon was re-examined on a third pass to remove lesions left in situ. In total, 
173 lesions were detected. Seventy-nine of the 173 lesions were detected by both WLE 
and AFE. The remaining 94 lesions were only seen with one of the two light techniques. 
Standard WLE was performed with a flexible video colonoscope (CF160, Olympus Opti-
cal Co, Tokyo, Japan) connected to a xenon light source. AFE was performed using the 
Onco-Life system (Xillix Technologies Corporation, Richmond, BC, Canada), attached to 
a standard fiberoptic colonoscope (CF40, Olympus Optical Co, Tokyo, Japan). The Onco-
Life system operates in two modes providing both autofluorescence and conventional 
white light imaging. Pressing a lever on the camera head allows the system to switch 
modes instantly. In the fluorescence mode, the tissue is exposed to blue and red light 
and simultaneously captures images in the green and red parts of the visible spectrum, 
which are combined to provide the fluorescence image. Blue light excites the tissue 
within the endoscopic field of view. The emitted green tissue autofluorescence passes 
via a dichroic mirror and a 490-560nm filter to an intensified charge coupled device. The 
red reflected light passes through a 650-750nm filter to a second charge coupled device. 
In general, the intensity of green autofluorescence is less in neoplastic than in normal 
tissue. The intensity of the red reflected light is less influenced by tissue changes. The 
two acquired images are combined by the digital signal processor to produce a single 
fluorescence image that can be displayed on a standard Red, Green, Blue monitor. The 
Onco-Life system also quantifies the fluorescence by providing a numeric representa-
tion of the red-to-green autofluorescence ratio (AFR).
Colorectal polyps
All lesions were graded by the endoscopist as either hyperplastic or adenomatous based 
on the macroscopic appearance. During AFE, AFR of each lesion was calculated. The size 
of each polyp was measured during the endoscopy using an open biopsy forceps with 
7mm span. The polyp size as judged during WLE was used for analysis. Lesions found 
during AFE and WLE were matched based on the location in the colon and comparison 
of the photographs taken during both procedures. All identified lesions were removed 
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during second or third pass (figure 1) and sent in for histology. Resected specimens were 
stained with haematoxylin and eosin. An expert gastrointestinal pathologist, who was 
blinded for the endoscopical judgment, evaluated all lesions. The WHO classification was 
adopted to classify the selected polyps as adenomatous or hyperplastic. Adenomatous 
lesions were further categorized according to histologic type, degree of dysplasia, and 
absence or presence of infiltrating carcinoma [11,12].
Statistical analysis
Descriptive statistics were used to analyze and report the data. Sensitivity, specificity 
and predictive values for predicting neoplasia with WLE and AFE were calculated by 
using histopathology as the reference value. The performance of AFR itself for differen-
tiating between hyperplastic and adenomatous polyps was analyzed by using receiver 
operating characteristic (ROC) curves analysis. In addition, diagnostic test statistics were 
calculated for polyps <6mm and ≥6mm. Differences between WLE and AFE were as-
sessed by using receiver operating characteristic (ROC) curves analysis and McNemar`s 
test. Statistical analysis was performed using the SPSS 18.0 program (SPSS Inc. Chicago, 
IL). A two-sided p-value of ≤ 0.05 was considered statistically significant.
reSultS
Polyp characteristics
In total, 79 colorectal polyps were observed in 31 patients and were evaluated with both 
WLE and AFE. The polyp characteristics are summarized in Table 1. Bowel preparation 
was excellent or good in 24 out of 31 patients (77%), and moderate in the remaining 
7 patients (23%). In case of a moderate bowel preparation, adequate lavage ensured 
adequate macroscopic visualization of polyps and ensured that the AFR was not altered 
by the resembling stool particles. Histopathology identified 19 hyperplastic and 60 
Table 1. Polyp characteristics
histopathological diagnosis
p-valuehyperplastic polyps Adenomatous polyps
Number (n) 19 60
Size
- Mean, in mm (95% CI) 5.6 (4.7 – 6.4) 4.9 (4.3 – 5.5) 0.20
- Categorized
<6mm 9 42
≥6mm 10 18
AFR, mean (95% CI) 0.46 (0.34 – 0.58) 0.85 (0.75 - 0.95) <0.001
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adenomatous polyps; 54 tubular adenomas with low grade dysplasia, 2 tubulovillous 
adenomas with low grade dysplasia, 1 traditional serrated adenoma, and 3 adenocarci-
nomas. There was no difference in size of hyperplastic polyps and adenomas (mean of 
5.6 mm and 4.9 mm, respectively (p=0.20)). Fifty-one polyps were <6mm and 28 polyps 
≥6mm. Adenomas had significantly higher AFR compared to hyperplastic polyps; mean 
0.85 and 0.46, respectively (p<0.001).
macroscopic differentiation
The diagnostic performance of WLE and AFE to macroscopically differentiate adeno-
matous and hyperplastic polyps is shown in Table 2. Sensitivity of WLE for identifying 
adenomas was 75% with a specificity of 32%. The area under the curve (AUC) was 0.53. 
Subdividing polyps in <6mm and ≥6mm, WLE had a sensitivity for identifying adenomas 
of 69% and 89%, respectively. During AFE, polyps were graded based on the autofluo-
rescence image and the numeric representation of the red-to-green AFR. Sensitivity of 
AFE for identifying adenomatous lesions was 87%, with a specificity of 47%. The AUC was 
0.67. After subdividing polyps in <6mm and ≥6mm, AFE had a sensitivity for identifying 
adenomas of 83% and 94%, respectively. Sensitivity and specificity, of WLE and AFE were 
not significantly different (p=0.09 and p=0.45, respectively).
Table 2. Diagnostic test characteristics WLE, AFE and AFR for predicting histology
AuC Sensitivity Specificity
WLE 0.53 75% 32%
AFE 0.67 87% 47%
AFR, cut-off
0.40 0.72 95% 50%
0.45 0.78 93% 63%
0.50 0.78 84% 72%
0.55 0.74 75% 72%
Afr
The performance of AFR itself for differentiating between hyperplastic and adenoma-
tous polyps was analyzed by using ROC curves analysis. The area under the curve was 
0.83. Diagnostic test characteristics were calculated for several AFR cut-off values (Table 
2). Focusing on a cut-off value of 0.45, sensitivity of AFR for identifying adenomas was 
93% with a specificity of 63%. The AUC was 0.78. After subdividing polyps in <6mm and 
≥6mm, AFR had a sensitivity for identifying adenomas of 90% and 100%, respectively. 
Sensitivity of AFR as compared to WLE for identifying adenomas was significantly higher 
(p=0.007). AFR had no significant higher specificity than WLE (p=0.10).
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diSCuSSiOn
This back to back comparative study provides evidence that AFE has better diagnostic 
test characteristics than conventional WLE for differentiating between hyperplastic and 
adenomatous colorectal polyps. Furthermore, we found that AFR performed better than 
when histology was predicted by the endoscopist based on the fluorescence image and 
AFR. AFR(0.45) improved diagnostic test statistics considerably as compared to WLE; sen-
sitivity increased from 75% to 93% (p=0.007) and specificity from 32% to 63% (p=0.10). 
Sensitivity of AFR was especially good in polyps ≥6mm.
Similar to our observations, previous studies demonstrated promising results for AFE 
as compared to WLE for differentiating between hyperplastic and adenomatous polyps 
[9,13,14]. However, to date no true comparison between both techniques could be made. 
To our knowledge, we performed the first back to back comparative study in which 
polyps were directly evaluated with both WLE and AFE prior to removal. Endoscopies 
were performed by two independent endoscopists who were unaware of the results of 
the other endoscopy. Another strength was that WLE was performed with high quality 
white light video colonoscopes which have the advantage over fiber-optic colonoscopes 
to provide high quality images. During AFE, on the other hand, a fiberoptic AFE system 
was used. This system does have a lower resolution than video AFE systems, however, it 
is unknown whether this is relevant for the fluorescence technique as data comparing 
these two systems are lacking. Furthermore, contrary to current video AFE systems, the 
Onco-Life system allows real-time and on-site calculation of the red-to-green AFR [14]. 
This makes the Onco-Life system suitable for differentiating between adenomatous and 
non-adenomatous polyps at the time of a colonoscopy.
Chromoendoscopy and narrow band imaging (NBI) are other techniques clinically ap-
plied for optical diagnosis of intestinal disorders. Chromoendoscopy involves the appli-
cation of stains or dyes during endoscopy to improve tissue visualization, characteriza-
tion and diagnosis of mucosal lesions. Chromoendoscopy has been shown to facilitate 
the differentiation of polyps [15]. However, chromoendoscopy is time consuming, 
operator dependent, and it is impossible to switch back to conventional colonoscopy 
which may influence adequate visualization of other mucosal lesions. These limitations 
have prevented the wide spread use of chromoendoscopy beyond few specified condi-
tions. NBI on the other hand, is more widely used. Primarily because of the ease of usage 
and availability at the switch of a button. NBI involves the use of narrow band pass filters 
in front of a conventional white light source to obtain tissue illumination at selected nar-
row wavelength bands. This provides optical enhancement of the vascular network and 
texture of the mucosa thereby assisting tissue characterization. NBI does not improve 
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adenoma detection but is a promising method for the prediction of colorectal polyp 
pathology [16,17]. However, the various described NBI classification systems, need to 
be further standardized and validated for use in routine clinical practice. Combining 
NBI and video AFE further improved diagnostic accuracy in the differential diagnosis 
of colorectal polyps [18]. Further development of the new endoscopic techniques are 
needed for reducing the number of unneeded polypectomies. Potentially it is useful 
to develop a video system that combines the benefits of WLE, NBI, and AFE, and allows 
real-time and on-site calculation of the red-to-green AFR.
The benefits of real-time histology would be far reaching. The capability to correctly 
differentiate hyperplastic and adenomatous lesions at the time of a colonoscopy would 
allow small distal hyperplastic polyps to be left in situ, or to “resect and discard” polyps 
without pathological assessment. Anecdotically, it could even be an option to resect 
diminutive and small adenomas without a further need for histopathology. The histo-
pathological diagnosis might not be needed as it is known that these diminutive and 
small adenomas have minimal risk of carrying advanced neoplasia. Second, a recent 
pooled multivariate analysis of postpolypectomy patients showed that the risk of meta-
chronous advanced colorectal neoplasia was strongly associated with the number, size, 
and location of prior adenomas, as well as patient age, but not with advanced histology 
[19]. Third, it is known that pathologists have only moderate agreement for differentiat-
ing non-advanced and advanced adenomas. In agreement with these findings, some 
postpolypectomy surveillance guidelines (e.g. the Dutch revised adenoma surveillance 
guideline and the United Kingdom NHS Bowel Cancer Screening Program) do not use 
advanced histology as indicator for surveillance interval, and only use size and number 
of adenomas [20,21]. Reducing the number of unneeded polypectomies would reduce 
the endoscopic and histopathologic workload, and the number of complications.
A limitation of our study was that this study was performed in a selected high-risk popu-
lation which influenced the predictive values. In addition, in the original study design 
AFE was routinely performed after WLE. However, as this could have introduced bias, the 
study was extended with additional patients. These patients underwent back to back 
endoscopy in a reverse order; AFE followed by WLE. The current study design enabled 
a true comparison of WLE and AFE for differentiating between hyperplastic and adeno-
matous polyps. All endoscopies were performed by two independent endoscopists who 
were unaware of the results of the prior endoscopy.
In conclusion, this study demonstrates that AFE has better diagnostic test characteristics 
than conventional White Light video Endoscopy for differentiating between hyper-
plastic and adenomatous polyps at the time of a colonoscopy. Furthermore, AFR with 
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a ROC determined cut-off value performed better than when histology was predicted 
by the endoscopist based on the fluorescence image and AFR. Further development of 
the new endoscopic technologies are needed for reducing the number of unnecessary 
polypectomies.
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The potential of CRC screening has been recognized. It is recommended to implement 
CRC screening with an organized population-based approach and appropriate quality 
assurance at all levels. The success of screening depends on the performance of individ-
ual components in the screening process. This thesis focused on individual components 
to improve and optimize population screening for CRC.
First we focused on the insufficient endoscopic capacity that serves as a barrier to 
CRC screening [1-6]. Introducing nurse endoscopists into gastrointestinal endoscopy 
service may provide a solution for the insufficient endoscopic capacity. In Chapter 2 we 
evaluated the views of gastroenterologists towards nurse performed endoscopy. Results 
showed that gastroenterologists are in general positive towards an important albeit re-
stricted role for nurse endoscopists. Potential benefits are recognized but concerns are 
expressed, including adequacy of training, quality, patient acceptance, and interference 
with training for gastroenterology fellows.
Previous studies already showed that nurse endoscopists are competent in perform-
ing gastroscopy and sigmoidoscopy [7,8]. However, the performance in colonoscopy 
remained to be elucidated. Only three small single center studies evaluated nurse per-
formed colonoscopy. These reports suggested that nurse endoscopists could become 
competent colonoscopists [9-11]. In Chapter 3, we described a large multicenter 
prospective study with ten trained nurse endoscopists who undertook in total 1000 
colonoscopies. Our results demonstrated that trained nurse endoscopists performed 
colonoscopies according to the international recognized quality standards, with high 
patient satisfaction. The cecal intubation rate was over 90%, adenoma detection rate 
was high at 26.8%, and only two complications occurred in 1000 colonoscopies (0.2%). 
In about a quarter of colonoscopies only, nurse endoscopists required assistance from 
the supervising gastroenterologist. Focusing on patient experiences, the vast majority 
of patients (95%) were satisfied with the endoscopic procedure. In addition, the majority 
of patients (72%) had no specific preference for a physician or nurse endoscopist.
In Chapter 4 we compared the endoscopic quality between nurse and physician per-
formed colonoscopy. Seven nurses and eight physicians with no endoscopic experience 
at baseline were enrolled in this large multicenter prospective study. Each endoscopist 
obtained endoscopic training, including a minimum of 100 colonoscopies. Next, each 
endoscopist performed 135 consecutive colonoscopies which were evaluated for en-
doscopic quality. Results demonstrated comparable endoscopic quality for nurse and 
physician endoscopists; the cecal intubation rates were over 90% (p=0.38), adenoma 
detection rates were over 25% (p=0.93), and complication rates were low; 0.5% (p=0.99). 
In both groups, the unassisted cecal intubation rates were just below 90% but gradually 
increased with the amount of colonoscopies performed, and were nowhere significantly 
different between nurse and physician endoscopists. Furthermore, we showed that in a 
Paul BW.indd   101 25-Apr-13   15:52:32 PM
102 Chapter 8
8
scenario where one gastroenterologist supervises three nurse endoscopists, personnel 
costs decline with 17 euro per colonoscopy compared to a gastroenterologist performed 
colonoscopy.
Our findings advocate the involvement of nurse endoscopists in colonoscopy, and 
should encourage decision-makers to support the development of nurse`s role in 
endoscopy. However, there are several important issues to the establishment of nurse 
endoscopy. Guidelines for nurse endoscopy training and criteria to maintain procedural 
competence after training should be defined. These guidelines should rely on avail-
able studies regarding the endoscopic skills of nurse endoscopists and be comparable 
with that of fellows. This in recognition of the educational differences between nurse 
and physician. Several professional groups already developed such guidelines [12]. If 
competence has been demonstrated, individual endoscopists should be credentialed 
by local institutions to perform the respective endoscopic procedures. In addition, clear 
job descriptions must define the scope of practice and specific responsibilities for nurse 
endoscopists and their supervisors. In the Netherlands for example, rules for health care 
professionals are set by the Individual Health Care Professionals Act (Wet BIG). This act 
authorizes nurses to perform specific delegated tasks, provided they are competent in 
performing the task as determined by training and accreditation, and perform the task 
under a pre-specified level of supervision. Nurses trained and judged competent for 
performing a specific procedure, will be judged accordingly, and are personally respon-
sible for the procedure. However, it is the responsibility for local institutions to define 
these responsibilities. These will also clarify the medico-legal implications and effective-
ness for the proposed strategy where gastroenterologists supervise nurse endoscopists. 
Furthermore, reimbursement policies should be adapted to facilitate a cost-effective 
and adequate reimbursement. Overcoming these issues will allow introduction of nurse 
endoscopists in the gastrointestinal endoscopic service. It`s time to come to action.
The pathology service also plays an important role in CRC screening. Accurate histopatho-
logical assessment is of paramount importance since the management of participants in 
the program depend on the quality and accuracy of the histopathologic diagnosis [13]. 
However, concern was raised about the reproducibility of the histological interpretation 
of colorectal lesions [14,15]. In Chapter 5, we evaluated the inter-observer variation in 
histological diagnosis of colorectal polyps detected in a CRC screening program. Results 
demonstrated very good inter-observer agreement in categorizing polyps as non-
adenomatous or adenomatous (kappa-value 0.88). However, inter-observer agreement 
was only moderate for differentiating between non-advanced and advanced adenomas 
(kappa-value 0.58). Furthermore, agreement was similar between general and expert 
pathologists one the one hand, and between expert pathologists on the other hand.
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Our data confirmed that the classification of advanced adenoma is subject to sub-
stantial inter-observer variation [14-21]. This has major clinical implications for patients 
with diminutive (1-5mm) and/or small (6-9mm) adenomas, as large adenomas (≥10mm) 
are already classified as advanced adenomas. A recent systematic review reported that 
diminutive and/or small adenomas were found to contain advanced histology in 12.5% 
of screened subjects in an average risk population [22]. Possible misclassification might 
therefore occur in a large proportion of patients. This has consequences on the surveil-
lance interval, as current guidelines also base the time interval for a surveillance colo-
noscopy on the presence of advanced adenoma [23]. Furthermore, postpolypectomy 
surveillance represents 22% of all colonoscopies [24]. In an era of limited endoscopy 
resources, it is of paramount importance to have objective criteria for risk stratification 
of subjects with adenoma for recommendations on surveillance interval [1-6].
Furthermore, it has been suggested that current postpolypectomy surveillance 
guidelines have limited predictability for advanced adenoma recurrence [25]. A risk 
profile based on cumulative findings from multiple previous colonoscopies might better 
stratify patients in high and low risk than the adenoma findings from the most recent ex-
amination [26]. In addition, recent evidence indicates that other factors than histological 
diagnosis, are stronger associated with the development of metachronous advanced 
adenomas. A pooled multivariate analysis of postpolypectomy patients showed that 
after four years of follow-up, the risk of metachronous advanced colorectal neoplasia 
was strongly associated with the number, size, and location of prior adenomas, as well 
as patient age. In the multivariate analysis, the presence of villous histology was only 
modestly associated, and the grade of dysplasia was not associated with metachronous 
advanced neoplasia [27]. Guidelines that do use the presence of advanced adenoma for 
risk stratification may reconsider these criteria given the subjectivity, the poor reproduc-
ibility, and the uncertainty on the role as a predictor of future risk.
In Chapter 6 we focused on the accuracy of identifying CRC pathology features known 
to be associated high microsatellite instability (MSI-H). These features are incorporated 
in various strategies to select cases for germline mutation analysis, in order to iden-
tify persons with Lynch syndrome. We evaluated the diagnostic test characteristics and 
inter-observer variation of MSI-H associated pathology features for identifying MSI-H 
CRC. Our data demonstrated that mucinous carcinoma, tumor-infiltrating lymphocytes 
and Crohns-like infiltrate were the best individual discriminators for distinguishing be-
tween MSI-H and microsatellite stable CRC. However, each of these characteristics had a 
moderate predictive performance (AUC of 0.63, 0.65 and 0.60, respectively). In addition, 
inter-observer agreement was only moderate for tumor-infiltrating lymphocytes and 
Crohns-like infiltrate (median kappa 0.38 and 0.48, respectively), but very good for mu-
cinous carcinoma (median kappa 0.86). Interpretation of the overall histopathological 
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appearance as suggestive for MSI-H performed better than any individual feature (Odds 
ratio 15.0 (95% CI 5.2-43.7), AUC 0.79). Although combining the MSI-H associated histol-
ogy features improved the diagnostic test characteristics, it identified only 80% of MSI-H 
tumors, and only with moderate inter-observer agreement (median kappa 0.53). In addi-
tion, diagnostic test characteristics and inter-observer agreement did not improve when 
only considering expert pathologists or adapting the histopathological scoring system.
Our data confirmed that the MSI-H associated pathology features are subject to lim-
ited diagnostic performance in the classification of CRC according to their molecular 
status, and that they are identified with moderate inter-observer agreement [28-30]. 
These results highlight the limitations of clinical strategies, like the revised Bethesda 
guidelines, which incorporate the MSI-H associated pathology features in their strategy 
to identify persons with Lynch syndrome. This has major implications as the revised 
Bethesda guidelines are considered the mainstay for selecting patients for molecular 
testing [31].
Besides the poor diagnostic performance and subjectivity in evaluating the MSI-H 
associated pathology features, the revised Bethesda guidelines have been criticized for 
being too complex [32,33]. In addition, the Bethesda guidelines are poorly implemented 
in clinical practice [34]. Together, this leads to a significant number of patients with LS 
who will remain undiagnosed. There is active debate about the optimal and standard 
approach to screening for MMR deficiency. A variety of strategies have been advocated, 
including mathematical algorithms to predict MMR gene mutation carriers based on 
personal and family history [35]. Other approaches rely heavily on routine tumor mo-
lecular testing of CRC in patients before age 50 years, before age 70 years or advice 
universal molecular testing [32,36-38].
The last issue addressed in this thesis affects the field of colon imaging. New endoscopic 
technologies like autofluorescence endoscopy attempt to optimize optical diagnostic 
tissue characterization. In Chapter 7 we compared autofluorescence endoscopy 
and white light video endoscopy for the differentiation between adenomatous and 
hyperplastic colorectal polyps at the time of a colonoscopy. This back to back compara-
tive study provided evidence that autofluorescence endoscopy has better diagnostic 
test characteristics than conventional white light video endoscopy for differentiating 
between hyperplastic and adenomatous polyps; the sensitivity for identifying adeno-
mas increased from 75% to 93% (p=0.007) and specificity increased from 32% to 63% 
(p=0.10).
Similar to our observations, previous studies demonstrated promising results for 
autofluorescence endoscopy for differentiating between hyperplastic and adeno-
matous polyps [39-41]. The benefits of real-time histology would be far reaching. The 
capability to correctly differentiate hyperplastic and adenomatous lesions at the time 
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of a colonoscopy would allow small distal hyperplastic polyps to be left in situ, or to 
“resect and discard” polyps without pathological assessment. It could even be an option 
to resect diminutive and small adenomas without a further need for histopathology. The 
histopathological diagnosis might not be needed as it is known that these diminutive 
and small adenomas have minimal risk of carrying advanced neoplasia [22]. In addition, 
results in chapter 5 demonstrated substantial inter-observer variation in the diagnosis 
of advanced adenoma. In agreement with these findings, some postpolypectomy sur-
veillance guidelines do not use advanced histology as indicator for surveillance interval, 
and only use size and number of adenomas [42,43]. Although the results of autofluores-
cence endoscopy are promising, further development of new endoscopic technologies 
are needed to reduce the number of unnecessary polypectomies.
In conclusion, we aimed to explore methods to improve and optimize population CRC 
screening. Pitfalls and opportunities were identified. Focusing on all individual compo-
nents in the screening process will further improve population screening for CRC.
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Samenvatting
Het promotieonderzoek dat nu voorligt omvat diverse aspecten in het bevolkingsonder-
zoek naar darmkanker. Darmkanker is een van de meest voorkomende vormen van kan-
ker. Een bevolkingsonderzoek kan veel sterfgevallen voorkomen en is kosteneffectief. 
Daarom wordt het bevolkingsonderzoek in diverse landen al uitgevoerd. In Nederland 
starten we vanaf september 2013. Het lifetime-risico op darmkanker bedraagt voor een 
willekeurige Nederlander 4-5%. Mensen tussen de 55 en 75 jaar worden iedere twee jaar 
uitgenodigd om deel te nemen, en ontvangen daarvoor een ontlastingstest (iFOBT). 
Bij een afwijkende uitslag volgt een uitnodiging voor een inwendig kijkonderzoek 
van de dikkedarm (colonoscopie). De schatting is dat met het bevolkingsonderzoek 
op termijn ongeveer 2400 sterfgevallen per jaar kunnen worden voorkomen. Het doel 
van dit proefschrift is de kwaliteit en haalbaarheid van het bevolkingsonderzoek naar 
darmkanker te verbeteren.
Momenteel is er onvoldoende capaciteit om het bevolkingsonderzoek uit te voeren. Het 
capaciteitsprobleem centreert zich rond de colonoscopie-capaciteit. Een colonoscopie 
is een inwendig kijkonderzoek van de gehele dikkedarm. Met dit kijkonderzoek kun-
nen we de voorstadia van darmkanker vinden én behandelen. Colonoscopieën worden 
verricht door artsen, voornamelijk MDL-artsen. Door de groeiende zorgkosten en het 
tekort aan MDL-artsen moeten alternatieven onderzocht worden. Daarom is er toene-
mende belangstelling voor de inzet van verpleegkundig endoscopisten. In hoofdstuk 
2 evalueren wij de mening van MDL-artsen over verpleegkundig endoscopisten. De 
resultaten laten zien dat MDL-artsen in het algemeen positief zijn over het inzetten van 
verpleegkundig endoscopisten voor het bevolkingsonderzoek naar darmkanker. Echter, 
er zijn wel zorgen over de opleiding, kwaliteit, en patiënt tevredenheid.
Eerdere studies lieten al zien dat verpleegkundig endoscopisten competent zijn in 
het verrichten van andere en relatief eenvoudigere kijkonderzoeken. Verpleegkundig 
endoscopisten zijn bijvoorbeeld competent in het verrichten van maagonderzoeken 
(gastroscopieën). Echter, er was nog weinig bekend over de competentie van verpleeg-
kundigen in het verrichten van colonoscopieën. Daarom hebben wij een groot onder-
zoek uitgevoerd met tien verpleegkundig endoscopisten die in totaal 1000 colonosco-
pieën hebben verricht. Dit onderzoek staat beschreven in hoofdstuk 3. Onze resultaten 
tonen aan dat verpleegkundig endoscopisten de colonoscopieën verrichten volgens de 
internationaal geldende kwaliteitscriteria, en met grote patiënt tevredenheid. Slechts in 
een kwart van de colonoscopieën hadden verpleegkundig endoscopisten hulp nodig 
van een superviserende MDL-arts.
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In hoofdstuk 4 vergelijken wij de kwaliteit en kosten van colonoscopieën verricht 
door verpleegkundigen en door artsen. Zeven verpleegkundigen en acht MDL-artsen 
in opleiding participeerden aan deze studie. Zij hadden bij aanvang van de studie geen 
colonoscopie ervaring. Elke deelnemer kreeg een colonoscopie-opleiding. Vervolgens 
verrichtte elke deelnemer 135 colonoscopieën. De resultaten tonen een goede en 
vergelijkbare kwaliteit tussen verpleegkundigen en artsen. Bovendien suggereren de 
resultaten dat met de introductie van verpleegkundig endoscopisten kosten bespaard 
kunnen worden.
Onze bevindingen tonen aan dat verpleegkundig endoscopisten een goede en waar-
devolle bijdrage kunnen leveren, en een oplossing bieden voor het capaciteitsprobleem 
in het bevolkingsonderzoek naar darmkanker. Beleidsmakers zouden de ontwikkeling 
van verpleegkundig endoscopisten moeten stimuleren.
De afdeling pathologie speelt ook een belangrijke rol in het bevolkingsonderzoek naar 
darmkanker. Een patholoog beoordeelt de gevonden darmafwijkingen op weefsel- en 
celniveau om te komen tot een diagnose. De behandeling en follow-up van deelnemers 
aan het bevolkingsonderzoek hangt sterk af van de kwaliteit en betrouwbaarheid van 
de diagnose. Een juiste diagnose is van levensbelang.
In het algemeen wordt aangenomen dat darmkanker zich ontwikkelt uit een bepaald 
type zwellingen van de darm, zogenaamde adenomen. Aanvullend wordt er onder-
scheid gemaakt tussen laag- en hoogrisico adenomen. In hoofdstuk 5 beschrijven wij 
de mate van overeenstemming tussen pathologen in de beoordeling van deze darmaf-
wijkingen. De resultaten laten zien dat pathologen niet-adenomen en adenomen goed 
van elkaar kunnen onderscheiden, maar laag- en hoogrisico adenomen slechts matig. 
Bovendien was de mate van overeenstemming vergelijkbaar tussen algemeen patho-
logen en pathologen met maag-, darm-, en leverziekten als aandachtsgebied. Daarom 
zou de behandeling en follow-up van deelnemers aan het bevolkingsonderzoek, niet 
afhankelijk moeten zijn van een onderscheid tussen laag- en hoogrisico adenomen.
In het bevolkingsonderzoek naar darmkanker is het ook belangrijk om personen met 
erfelijke vormen van darmkanker te herkennen. Zij behoeven veelal een andere behan-
deling en follow-up dan mensen zonder erfelijke vorm van darmkanker (sporadische 
darmkanker). Ongeveer 5% van de darmkanker is erfelijk. Het Lynch syndroom is de 
meest voorkomende vorm van erfelijke darmkanker. hoofdstuk 6 beschrijft de waarde 
van pathologiekenmerken voor het herkennen van Lynch syndroom. De pathologie-
kenmerken zijn opgenomen in diverse strategieën om Lynch syndroom te identificeren. 
Echter, er was onzekerheid over de diagnostische waarde van deze kenmerken. Onze 
resultaten laten zien, dat de pathologiekenmerken weinig diagnostische waarde heb-
ben in het identificeren van Lynch syndroom. Daarom zouden de betreffende patholo-
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giekenmerken geen onderdeel moeten uitmaken van strategieën voor Lynch syndroom 
identificatie.
Het laatste onderwerp van het proefschrift betreft nieuwe beeldvormende technieken. 
Nieuwe beeldvormende technieken kunnen mogelijk ook een bijdrage leveren in het 
bevolkingsonderzoek naar darmkanker. We hebben ons gericht op de autofluorescentie 
endoscopie. Dit inwendig kijkonderzoek van de dikkedarm maakt gebruik van een alter-
natieve lichtbron. Er werd gesuggereerd dat autofluorescentie endoscopie onderscheid 
zou kunnen maken tussen niet-adenomen en adenomen. Daarmee zou het mogelijk zijn 
om niet-adenomen in de darm te laten zitten met als gevolg een efficiënter onderzoek 
en minder risico op complicaties. In hoofdstuk 7 vergelijken we de autofluorescentie 
endoscopie met een standaard witlicht colonoscopie voor het onderscheid tussen niet-
adenomen en adenomen. De resultaten laten zien dat de autofluorescentie endoscopie 
beter onderscheid kan maken tussen niet-adenomen en adenomen, dan standaard 
witlicht colonoscopie. Echter, de betrouwbaarheid van de autofluorescentie diagnose 
is niet voldoende om de niet-adenomen in de darm achter te laten. Het verdient aan-
beveling om de nieuwe beeldvormende technieken verder te ontwikkelen en zo een 
real-time diagnose mogelijk te maken.
Concluderend hebben wij in het proefschrift diverse methoden onderzocht om de 
kwaliteit en haalbaarheid van het bevolkingsonderzoek naar darmkanker te verbeteren. 
Valkuilen en kansen werden ontdekt. Met een verdere verbetering van alle afzonderlijke 
stappen in het bevolkingsonderzoek, zal het succes en de waarde van het bevolkings-
onderzoek verder toenemen.
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